Podcasts about emory university school

Join Dr. Stephanie and Dr. Saulnier as they discuss her presentation at the Converge Autism Summit on broadening the autism spectrum.https://nacsatl.com/They will discuss:The key features of autismHow Autism symptoms are expressed differently in male and femaleThe role of racial, ethnic, and socioeconomic disparities in misdiagnosis of autismCommon overlaps and differential diagnosisDr. Saulnier obtained her doctorate in Clinical Psychology from the University of Connecticut. She trained and worked at the Yale Child Study Center's Autism Program for nearly a decade before relocating to Emory University School of Medicine and the Marcus Autism Center in Atlanta, GA, where she directed a large-scale clinical research program. In 2018, she opened her own company, Neurodevelopmental Assessment & Consulting Services, where she specializes in diagnostic assessment, as well as teaching and training for autism spectrum and related disorders. Dr. Saulnier has published over 50 articles, written two books, and she is an author on the Vineland Adaptive Behavior Scales, Third Edition.Looking for Assessment in GA? https://www.psychologytoday.com/us/therapists/neurodevelopmental-assessment-consulting-svc-decatur-ga/409874

Neuro-ophthalmic deficits significantly impair quality of life by limiting participation in employment, educational, and recreational activities. Low-vision occupational therapy can improve cognition and mental health by helping patients adjust to visual disturbances. In this episode, Katie Grouse, MD, FAAN, speaks with Sachin Kedar, MD, FAAN, author of the article “Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Kedar is the Cyrus H Stoner professor of ophthalmology and a professor of neurology at Emory University School of Medicine in Atlanta, Georgia. Additional Resources Read the article: Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @AIIMS1992 Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Kedar: Thank you, Katie. This is Sachin Kedar. I'm a neuro-ophthalmologist at Emory University, and I've been doing this for more than fifteen years now. I trained in both neurology and ophthalmology, with a fellowship in neuro-ophthalmology in between. It's a pleasure to be here. Dr Grouse: Well, we are so happy to have you, and I'm just so excited to be discussing this article with you, which I found to be a real treasure trove of useful clinical information on a topic that many find isn't covered enough in their neurologic training. I strongly recommend all of our listeners who work with patients with visual disturbances to check this out. I wanted to start by asking you what you hope will be the main takeaway from this article for our listeners? Dr Kedar: The most important takeaway from this article is, just keep vision on your radar when you are evaluating your patients with neurological disorders. Have a list of a few symptoms, do a basic screening vision, and ask patients about how their vision is impacting the quality of life. Things like activities of daily living, hobbies, whether they can cook, dress, ambulate, drive, read, interact with others. It is very important for us to do so because vision can be impacted by a lot of neurological diseases. Dr Grouse: What in the article do you think would come as the biggest surprise to our listeners? Dr Kedar: The fact that impairment of vision can magnify and amplify neurological deficits in a lot of what we think of as core neurological disorders should come as a surprise to most of the audience. Dr Grouse: On that note, I think it's probably helpful if you could remind us about the types of visual disturbances we should be thinking about and screening for in our patients? Dr Kedar: Patients who have neurological diseases can have a whole host of visual deficits. The simplest ones are deficits of central vision. They can have problems with their visual field. They can have abnormalities of color vision or even contrast sensitivity. A lot of our patients also complain of light sensitivity, eyes feeling tired when they're doing their usual stuff. Some of our patients can have double vision, they can have shaky vision, which leads to their sense of imbalance and maybe a fall risk to them. Dr Grouse: It's really helpful to think about all the different aspects in which vision can be affected, not just sort of the classic loss of vision. Now, your article also serves as a really important reminder, which you alluded to earlier, about how impactful visual disturbances can be on daily activities. Could you elaborate a little further on this, and particularly the various domains that can be affected when there are visual disturbances present? Dr Kedar: So, when I look at how visual disturbances affect quality of life, I look at two broad categories. One is activities of basic daily living. These would be things like, are you able to cook? Are you able to ambulate not just in your home, but in your neighborhood? Are you able to drive to your doctor's appointment or to visit with your family? Are you able to dress yourself appropriately? Are you able to visualize the clothing and choose them appropriately? And then the second category is recreational activities. Are you able to read? Are you able to watch television? Are you able to visit the theatre? Are you able to travel? Are you able to participate in group activities, be it with your family or be it with your social group? It is very important for us to ask our patients if they have problems doing any of this because it really can adversely impact the quality of life. Dr Grouse: I think, certainly with all the things we try to get through talking with our patients, this may not be something that we do spend a lot of time on. So, I think it's it is a good reminder that when we can, being able to ask about these are going to be really important and help us hit on a lot of other things we may not even realize or know to ask about. Now, I was really struck when I was reading your article by the meta-analysis that you had quoted that had showed 47% higher risk of developing dementia among the visually impaired compared to those without visual impairments. Should we be doing more in-depth visual testing on all of our patients with cognitive symptoms? Dr Kedar: This is actually the most interesting part of this article, and kind of hones in on the importance of vision in neurological disorders. Now I want to clarify that patients with visual disorders, it's not a causative influence on dementia, but if you have a patient with an underlying cognitive disorder, any kind of visual disturbance will significantly make it worse. And this has been shown in several studies, both in the neurologic and in the ophthalmological literature. So, I quoted one of the big meta-analysis over there, but studies have clearly shown that if you have these patients and treat them for their visual deficits, their cognitive indices can actually significantly improve. To answer your question, I would say a neurologist should include basic vision screening as part of every single evaluation. Now, I know it's a hard thing in, you know, these days when we are literally running on the hamster wheel, but I can assure you that it won't take you more than 2 to 3 minutes of your time to do this basic screening; in fact, you can have one of your assistants included as part of the vital signs assessment. What are these basic screening tools? Measure the visual acuity for both near and distance. Check and see if their visual field's off with the confrontation. Look at their eye movements. Are they able to move their eyes in all directions? Are the eyes stable when they're trying to fixate on a particular point? I think if you can do these basic things, you will have achieved quite a bit. Dr Grouse: That's really helpful, and thanks for going through some of the standard, or really, you know, solid basic foundation of visual testing we should be thinking about doing. I wanted to move on to some more details about the visual disturbances. You made an excellent point that there are many types of primary ophthalmologic conditions that can cause visual disturbances that we should keep in mind. So maybe not things that we think about a lot on a day-to-day basis, but, you know, are still there and very common. What are some of the most common ones, and when should we be referring them to see an ophthalmologist? Dr Kedar: So, it depends on the age group of your patient population. Now, the majority of us are adult neurologists, and so the kinds of ophthalmic conditions that we see in this population is going to be different from the pediatric age group. So in the adult population, we might see patients with uncorrected refractive error, presbyopia, patients who have cataracts creep on them, they may have glaucoma, they may have macular degeneration, and these tend to have a slightly higher incidence in the older age group. Now for those of us who are taking care of the younger population, uncorrected refractive errors, strabismus and amblyopia tend to be fairly common causes of visual deprivation in this age group. What I would encourage all of our neurologists is, make sure that your patients get a basic eye examination at least once a year. Just like you want them to go to their primary care and get an annual maintenance visit, everybody should go to the ophthalmologist or the optometrist and get a basic examination. And, if you're resourceful enough, have your patients bring a copy of that assessment. Whether it is normal or there's some abnormality, it is going to help you in the management. Dr Grouse: Absolutely. I think that's a great piece of advice, to think of it almost, like, them seeing their primary care doctor, which of course we offer encourage our patients to do, thinking of this as another very important piece of standard primary care. If a patient comes to you reporting difficulty reading due to possible visual disturbances, I'm curious, can you walk us through how you would approach this evaluation? Dr Kedar: It is not a very common presenting complaint of our patients, even in the neuro-ophthalmology clinic. It's a very rare patient that I see who comes and says, I cannot read or, I have difficulty reading. Most of the patients will come saying, oh, I cannot see. And then you have to dig in to find out, what does that actually mean? What can you not see? Is it a problem in your driving? Is it a problem in your reading? Or is it a problem that occurs at all times? Now you asked me, how do you approach this evaluation? One of the things that all of us, whether we are neurologists, ophthalmologists, or neuro-ophthalmologists, forget to do is to actually have the patient read a paragraph, a sentence, when they are in clinic. And that will give you a lot of ideas about what might actually be going wrong with the patient. Now, as far as how do I approach this evaluation, I will do a basic screening examination to make sure that their visual acuity is good for both distance and near. A lot of us tend to do either distance or near and we will miss the other parameter. You want to do a basic confrontation visual field to make sure that they do not have any subtle deficits that's impacting their ability to read. Examine the eye movements, do a fundoscopic examination. Now, once you've done this basic screening, as a neurologist, you already have some idea of whether your patient has a lesion along the visual pathways. If you suspect that this is a problem with, say, the visual pathways, ask your ophthalmology colleague to do a formal visual field assessment, and that'll pick up subtle deficits of central visual field. And lastly, don't forget higher visual function testing or cortical visual function testing. So basically, you're looking for neglect, phenomenon, or simultanagnosia, all of which tends to have an impact on reading. So, in the manuscript I have a schema of how you can approach a patient with reading difficulties, and in that ischemia you will see categories of where things can go wrong during the process of reading. And if you can approach your patient systematically through one of those domains, there's a fairly good chance that you'll be able to pick up a problem. Dr Grouse: Going a little further on to when you do identify problems with loss of central or peripheral vision, what are some strategies for symptomatic management of these types of visual disturbances? Dr Kedar: As a neurologist, if you pick up a problem with the vision, you have to send this patient to an eye care provider. The vast majority of people who have visual disturbances, it's from an eye disease. You know, as I alluded to earlier, it can be something as simple as uncorrected refractive error, and that can be fixed easily. A lot of patients in our older age group will have dry eye syndrome, which means they are unable to adequately lubricate the surface of the eye, and as a result, it degrades the quality of their vision. So, they tend to get intermittent episodes of blurred vision, or they tend to get glare. They tend to get various forms of optical aberration. Patients can have cataracts, patients can have glaucoma or macular degeneration. And in all of those instances, the goal is to treat the underlying disease, optimize the vision, and then see what the residual deficit is. By and large, if a patient has a problem with the central vision, then magnification will help them for activities that they perform at near; say, reading. Now for patients with peripheral vision problem, it's a different entity altogether. Again, once you've identified what the underlying cause is, your first goal is to treat it. So, for example, if your patient has glaucoma, which is affecting peripheral vision, you're going to treat glaucoma to make sure that the visual field does not progress. Now a lot of what happens after that is rehabilitation, and that is always geared towards the specific activities that are affected. Is it reading? Is it ambulating? Is it watching television? Is it driving? And then you can advise as a neurologist, you can advise your occupational therapist or low vision specialist and say, hey, my patient is not able to do this particular activity. Can we help them? Dr Grouse: Moving on from that, I wanted to also hit on your approach when patients have disorders of ocular motility. What are some things you can do for symptomatic management of that? Dr Kedar: So, patients with ocular motility can have two separate symptoms. Two, you know, two disabling symptoms, as they would call it. One is double vision and the other is oscillopsia, or the feeling or the visualization of the environment moving in response to your eyes not being able to stay still. Typically, you would see this in nystagmus. Now, let's start with diplopia. Diplopia is a fairly common presenting complaint for neurologists, ophthalmologists, and the neuro-ophthalmologist. The first aspect in the management of diplopia is to differentiate between monocular diplopia and binocular diplopia. Now, monocular diplopia is when the double vision persists even after covering one eye. And that is never a neurological issue. It's almost always an ophthalmic problem, which means the patient will then have to be assessed by an eye care provider to identify what's causing it. And again, refractive error, cataracts, opacities, they can do it. Now, if the patient is able to see single vision by covering one eye at a time, that's binocular diplopia. Now, in patients with binocular diplopia in the very early stages of the disease, the standard treatment regimen is just monocular occlusion. Cover one eye, the diplopia goes away, and then give it time to improve on its own. So, this is what we would typically do in a patient with, say, acute sixth nerve palsy or fourth nerve palsy or third nerve palsy, maybe expect spontaneous improvement in a few months. Now if the double vision does not improve and persists long term, then the neuro-ophthalmologist or the ophthalmologist will monitor the amount of deviation to see if it fluctuates or if it stays the same. So, what are the treatment options that we have in a patient who absolutely refuses any intervention or is not a candidate for any intervention? Monocular occlusion still remains the viable option. Now, patients who have stable ocular deviation can benefit from using prisms in their glasses, or they can be sent to a surgeon to have a strabismus surgery that can realign their eyes. So, again, a broad answer, but there are options available that we can use. Dr Grouse: Thank you for that overview. I think that's just really helpful to keep in mind as we're working with these patients and thinking about what their options are. And then finally, I wanted to touch on patients with higher-order vision processing and attention difficulties. What are some strategies for them? Dr Kedar: These are frankly the most difficult patients that I get to manage in my clinic, simply because there is no effective therapies for managing them. In fact, I think neurologists are far better at this than ophthalmologists or even neuro-ophthalmologists. In patients with attentional disorders, everything boils down to the underlying cause, whether you can treat it or whether it is a slowly progressive, you know, condition, such as from neurodegenerative diseases. And that tailors our goals towards therapy. The primary goal is for safety. A lot of these patients who have visual disturbances from vision processing or attention, they are at accident and fall risk. They have problems with social interactions. And, importantly, there is a gap of understanding of what's going on, not just from their side but also from the family's side. So, I tend to approach these patients from a safety perspective and social interaction perspective. Now, I have a table listed in the manuscript which will go into details of what the specific things are. But in a nutshell, if your patient has neglect in a specific part of the visual field, they have accident risk on that side. Simple things like walking through a doorway, they can hurt their shoulders or their knees when they bang into the wall on that side because they are unable to judge what's on the other side. Another example would be a patient who has simultanagnosia or a downgaze policy, such as from progressive super nuclear policy. They are unable to look down fast enough, or they are simply unable to look down and appreciate things that are on the floor, and so they can trip and fall. Walking downstairs is also not a huge risk because they are unable to judge distances as they walk down. A lot of what we see in these patients are things that we have to advise occupational therapists and help them improve these safety parameters at home. Another thing that we often forget is patients can inadvertently cause a social incident when they tend to ignore people on their affected side. So, if there is a family gathering, they tend to consistently ignore a group of people who are sitting on the affected side as opposed to the other side. And I've had more than a few patients who've come and said that, I may have offended some of my friends and family. In those instances, it's always helpful when they are in clinic to demonstrate to the family how this can be awkward and how this can be mitigated. So, having everybody sit on one side is a useful strategy. Advise your family and friends before a gathering that, hey, this may happen. And it is not because it is deliberate, but it's because of the medical condition. And that goes a lot, you know, further in helping our patients come out of social isolation because they are also afraid of offending people, you know. And they can also participate socially, and it can overall improve their quality of life. Dr Grouse: That's a really helpful tip, and something I'll keep in mind with my patients with neglect and visual field cuts. Thank you so much for coming to talk with us today. Your article has been so helpful, and I urge everybody listening today to take a look. Dr Kedar: Thank you, Katie. It was wonderful talking to you. Dr Grouse: I've been interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Despite persistent obstacles—from intergenerational pay inequity and earning just 63.7 cents for every dollar made by a white guy for the same work, to constant surveillance and doubt—Black women consistently excel in their chosen fields and rise to leadership positions. In this episode, we're joined by powerful Black women in leadership to discuss the glass ceilings, glass cliffs, pink ghettos, and other obstacles they've faced—and the strategies they've used to triumph against the odds.Joining me to discuss these crucial issues are our very special guests: Verna Williams: Verna Williams is the CEO of Equal Justice Works. In her role as CEO, Verna has continued to advance the mission of Equal Justice Works to create opportunities for leaders to transform their passion for equal justice into a lifelong commitment to public service. Verna previously served as the dean of the University of Cincinnati College of Law, and founded and co-directed the Judge Nathaniel Jones Center for Race, Gender, and Social Justice at the University of Cincinnati. She was also the vice president and director of educational opportunities at the National Women's Law Center, where she focused on gender disparity in education.Lynell Cadray: Lynell Cadray is University Ombuds and Senior Adviser to the President at Emory University. Since arriving at Emory in 1994, Cadray has served in numerous roles, including vice provost of equity and inclusion; associate dean of enrollment and student services and chief diversity officer at Nell Hodgson Woodruff School of Nursing; and dean of admission and financial aid and chief diversity officer at Emory University School of Law. Dr. Rachel Westerfield: Dr. Rachel Westerfield is the Director of Solution Design at Slack. Dr. Westerfield's Professional Services team is responsible for driving digital growth and large-scale, enterprise-wide transformation for Slack's most complex and strategic customers across industries on a global scale. Before joining Slack in 2019, she was a Strategy and Business Process Transformation leader at Accenture and a Management Consultant in Organizational Leadership and Development at Nestle Purina.Check out this episode's landing page at MsMagazine.com for a full transcript, links to articles referenced in this episode, further reading and ways to take action.Support the show

On this episode of Talking Away The Taboo, Estie Rose, MS, CGC, Heather Hipp, MD, and Gail Heyman, join Aimee Baron, MD for the second episode of our 5-part IWSTHAB x JSCREEN Podcast series is all about Fragile X. When people think of genetic testing before pregnancy, they often think of Tay-Sachs or cystic fibrosis—but Fragile X is just as important and far less understood. In this episode, Estie Rose and Dr. Heather Hipp explain the difference between recessive and X-linked conditions, what it means to be a Fragile X carrier, and how it can affect fertility and family planning. We also hear from Gail Heyman, who shares her deeply personal journey navigating Fragile X in her own family—and how that led her to advocacy. Whether you're building your family or supporting someone who is, this episode is filled with insight, honesty, and heart. -Click here to watch Part 1: Introduction to Genetics and Infertility More about Estie:  Estie Rose is a certified genetic counselor at jscreen. She has a special interest in community education and serves as a resource for individuals who are facing genetic health issues. Connect with Estie:  -Follow her on Instagram More about Heather: Dr. Heather Hipp is a Reproductive Endocrinology and Infertility (REI) physician and an Associate Professor at Emory University School of Medicine. She earned her undergraduate degree at Duke University and then her MD degree at Emory University, where she continued her training in residency and fellowship. She is the Program Director for the REI fellowship at Emory and serves as chair for the American Society for Reproductive Medicine Education Committee. Her profession memberships include American College of Obstetrics and Gynecology, American Society for Reproductive Medicine, Alpha Omega Alpha Honor Society, and American Gynecological & Obstetrical Society. She is also on the National Fragile X Foundation Scientific and Clinical Advisory Committee. Her research focuses on women who are carriers for the fragile X mutation and their risk of premature ovarian insufficiency, as well as trends and outcomes of in-vitro fertilization (IVF) in the United States. More about Gail:   Gail Heyman is a passionate advocate and leader in the Fragile X community. After her son was diagnosed in 1989, she co-founded the Fragile X Association of Georgia and has served as its director ever since. Her family's experience—spanning three generations affected by Fragile X conditions—fuels her tireless work to raise awareness, promote research, and support others navigating similar challenges. Gail also serves on JScreen's advisory board and has received national recognition for her leadership in genetic advocacy and inclusion. -Click here to learn more about Gail's story -Check out Carly Heyman's book, My eXtra Special Brother -Learn more about Fragile X here Connect with JScreen:  -Visit their website -Coupon Code: IWSTHAB18 for $18 off initial testing (no expiration date on this offer) -Follow JScreen on Instagram Connect with us:  -Check out our Website - Follow us on Instagram and send us a message -Watch our TikToks -Follow us on Facebook -Watch us on YouTube

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease. Annals of Family Medicine 2025. Discussion by:Guest:Barbara Yawn, MD, MSc, MPHAdjunct Professor, Department of Family and Community HealthUniversity of Minnesota Former Chief Scientific Officer at the COPD Foundation2. Optimal dietary patterns for healthy aging. Nature Medicine. Discussion by:Guest:Jessica Stieritz, MD Resident– Family Medicine Residency Program Jefferson Health – Abington3. Amount and intensity of daily total physical activity, step count and risk of incident cancer. British Journal of Sports Medicine. Discussion by:Guest:William Callahan, D.O. Associate Director – Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

On this episode, Cathleen McCabe, MD, and Laura Enyedi, MD, chat with guest Mara Schenker, MD, about her career as an orthopedic surgeon and her role as chief medical information officer at Grady Memorial Hospital. Intro 0:04 Mara Schenker, MD 0:20 Tell us about the titles you hold. What does CMIO mean? 0:39 How long have you been doing medical informatics? … How important is that skill and background in technology now? What do you see in the future for AI and what is it going to do for us? 1:45 The hosts and guest discuss the use of AI in medicine. 4:27 The hosts and guests discuss the ups and downs of artificial intelligence. 10:53 What do you like to use AI for right now? 11:46 The hosts and guests discuss the use of AI in everyday life. 14:34 How did you become interested in orthopedic surgery? What were gender disparities like in the field of orthopedics? 15:33 The hosts and guest discuss mentorship and the impacts of mentors. 18:53 The hosts and guest discuss women in leadership. 19:52 How did you build and maintain your surgical confidence? 23:52 Peak: Secrets from the New Science of Expertise and The Confidence Code 28:10 Grit 28:40 Schenker describes her ‘deliberate practice' talk. 28:56 How do you go about bringing on new technology? 29:25 The hosts and guest discuss building confidence, building skill and asking for help. 30:58 How do you find balance with everything you do? 33:32 The hosts and guest discuss when to say ‘yes' and when to say ‘no'. 35:56 What are your words of wisdom and advice for trainees and young physicians? 38:38 The hosts and guest discuss being brave and going with your gut. 42:07 Thanks 44:14 Laura Enyedi, MD, is a professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. Mara Schenker, MD, is an orthopedic trauma surgeon and chief of orthopedics at Grady Memorial Hospital and professor of orthopedics at Emory University School of Medicine. She is also the associate chief medical information officer for Grady, board certified in clinical informatics and has extensive EHR build and analytics certifications. Schenker is a member of the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association.  As the 2001 World Champion in Taekwondo, she has a particular interest in the intersection between sports and surgery, as it relates to human performance optimization. Her clinical practice is based at Grady Memorial Hospital. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Disclosures: The hosts and guest report no relevant financial disclosures.

Diagnosing and differentiating among the many possible localizations and causes of vision loss is an essential skill for neurologists. The approach to vision loss should include a history and examination geared toward localization, followed by a differential diagnosis based on the likely location of the pathophysiologic process.  In this episode, Aaron Berkowitz, MD, PhD, FAAN speaks with Nancy J. Newman, MD, FAAN, author of the article “Approach to Vision Loss” in the Continuum® April 2025 Neuro-ophthalmology issue.  Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology at the University of California San Francisco in the Department of Neurology and a neurohospitalist, general neurologist, and clinician educator at the San Francisco VA Medical Center at the San Francisco General Hospital in San Francisco, California.  Dr. Newman is a professor of ophthalmology and neurology at the Emory University School of Medicine in Atlanta, Georgia.  Additional Resources Read the article: Approach to Vision Loss Subscribe to Continuum®: shop.lww.com/Continuum  Earn CME (available only to AAN members): continpub.com/AudioCME  Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com  Social Media facebook.com/continuumcme  @ContinuumAAN  Host: @AaronLBerkowitz  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Nancy Newman about her article on the approach to visual loss, which she wrote with Dr Valerie Biousse. This article appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, Dr Newman. I know you need no introduction, but if you wouldn't mind introducing yourself to our listeners. Dr Newman: Sure. My name's Nancy Newman. I am a neurologist and neuro-ophthalmologist, professor of ophthalmology and neurology at the Emory University School of Medicine in Atlanta, Georgia. Dr Berkowitz: You and your colleague Dr Biousse have written a comprehensive and practical article on the approach to visual loss here. It's fantastic to have this article by two of the world's leading experts and best-known teachers in neuro-ophthalmology. And so, readers of this article will find extremely helpful flow charts, tables and very nuanced clinical discussion about how to make a bedside diagnosis of the cause of visual loss based on the history exam and ancillary testing. We'll talk today about that important topic, and excited to learn from you and for our listeners to learn from you. To begin, let's start broad. Let's say you have a patient presenting with visual loss. What's your framework for the approach to this common chief concern that has such a broad differential diagnosis of localizations and of causes? Where do you start when you hear of visual loss? How do you think about this chief concern? Dr Newman: Well, it's very fun because this is the heart of being a neurologist, isn't it? Nowhere in the nervous system is localization as important as the complaint of vision loss. And so, the key, as any neurologist knows, is to first of all figure out where the problem is. And then you can figure out what it is based on the where, because that will limit the number of possibilities. So, the visual system is quite beautiful in that regard because you really can exquisitely localize based on figuring out where things are. And that starts with the history and then goes to the exam, in particular the first localization. So, you can whittle it down to the more power-for-your-buck question is, is the vision lost in one eye or in two eyes? Because if the vision loss clearly, whether it's transient or persistent, is in only one eye, then you only have to think about the eyeball and the optic nerve on that side. So, think about that. Why would you ever get a brain MRI? I know I'm jumping ahead here, but this is the importance of localization. Because what you really want to know, once you know for sure it's in one eye, is, is it an eyeball problem---which could be anything from the cornea, the lens, the vitreous, the retina---or is it an optic nerve problem? The only caveat is that every once in a while, although we trust our patients, a patient may insist that a homonymous hemianopia, especially when it's transient, is only in the eye with the temporal defect. So that's the only caveat. But if it's in only one eye, it has to be in that side eyeball or optic nerve. And if it's in two eyes, it's either in both eyeballs or optic nerves, or it's chiasmal or retrochiasmal. So that's the initial approach and everything about the history should first be guided by that. Then you can move on to the more nuanced questions that help you with the whats. Once you have your where, you can then figure out what the whats are that fit that particular where. Dr Berkowitz: Fantastic. And your article with Dr Biousse has this very helpful framework, which you alluded to there, that first we figure out, is it monocular or binocular? And we figure out if it's a transient or fixed or permanent deficit. So, you have transient monocular, transient binocular, fixed monocular, fixed binocular. And I encourage our listeners to seek out this article where you have a table for each of those, a flow chart for each of those, that are definitely things people want to have printed out and at their desk or on their phone to use at the bedside. Very helpful. So, we won't be able to go through all of those different clinical presentations in this interview, but let's focus on monocular visual loss. As you just mentioned, this can be an eye problem or an optic nerve problem. So, this could be an ophthalmologic problem or a neurologic problem, right? And sometimes this can be hard to distinguish. So, you mentioned the importance of the history. When you hear a monocular visual loss- and with the caveat, I said you're convinced that this is a monocular visual problem and not a visual field defect that may appear. So, the patient has a monocular deficit, how do you approach the history at trying to get at whether this is an eye problem or an optic nerve problem and what the cause may be? Dr Newman: Absolutely. So, the history at that point tends not to be as helpful as the examination. My mentor used to say if you haven't figured out the answer to the problem after your history, you're in trouble, because that 90% of it is history and 10% is the exam. In the visual system, the exam actually may have even more importance than anywhere else in the neurologic examination. And we need as neurologists to not have too much hubris in this. Because there's a whole specialty on the eyeball. And the ophthalmologists, although a lot of their training is surgical training that that we don't need to have, they also have a lot of expertise in recognizing when it's not a neurologic problem, when it's not an optic neuropathy. And they have all sorts of toys and equipment that can very much help them with that. And as neurologists, we tend not to be as versed in what those toys are and how to use them. So, we have to do what we can do. Your directive thalmoscope, I wouldn't throw it in the garbage, because it's actually helpful to look at the eyeball itself, not just the back of the eye, the optic nerve and retina. And we'll come back to that, but we have in our armamentarium things we can do as neurologists without having an eye doctor's office. These include things like visual acuity and color vision, confrontation, visual fields. Although again, you have to be very humble. Sometimes you're lucky; 30% of the time it's going to show you a defect. It has to be pretty big to pick it up on confrontation fields. And then as we say, looking at the fundus. And you probably know that myself and Dr Biousse have been on somewhat of a crusade to allow the emperor's new clothes to be recognized, which is- most neurologists aren't very comfortable using the direct ophthalmoscope and aren't so comfortable, even if they can use it, seeing what they need to see. It's hard. It's really, really hard. And it's particularly hard without pupillary dilation. And technology has allowed us now with non-mydriatic cameras, cameras that are incredible, even through a small pupil can take magnificent pictures of the back of the eye. And who wouldn't rather have that? And as their cost and availability- the cost goes down and their availability goes up. These cameras should be part of every neurology office and every emergency department. And this isn't futuristic. This is happening already and will continue to happen. But over the next five years or so… well, we're transitioning into that. I think knowing what you can do with the direct ophthalmoscope is important. First of all, if you dial in plus lenses, you can't be an ophthalmologist, but you can see media opacities. If you can't see into the back of the eye, that may be the reason the patient can't see out. And then just seeing if someone has central vision loss in one eye, it's got to be localized either to the media in the axis of vision; or it's in the macula, the very center of the retina; or it's in the optic nerve. So, if you get good at looking at the optic nerve and then try to curb your excitement when you saw it and actually move a little temporally and take a look at the macula, you're looking at the two areas. Again, a lot of ophthalmologists these days don't do much looking with the naked eye. They actually do photography, and they do what's called OCT, optical coherence tomography, which especially for maculopathies, problems in the macula are showing us the pathology so beautifully, things that used to be considered subtle like central serous retinopathy and other macula. So, I think having a real healthy respect for what an eye care provider can do for you to help screen away the ophthalmic causes, it's very, very important to have a patient complaining of central vision loss, even if they have a diagnosis like multiple sclerosis, you expect that they might have an optic neuritis… they can have retinal detachments and other things also. And so, I think every one of these patients should be seen by an eye care provider as well. Dr Berkowitz: Thank you for that overview. And I feel certainly as guilty as charged here as one of many neurologists, I imagine, who wish we were much better and more comfortable with fundoscopy and being confident on what we see. But as you said, it's hard with the direct ophthalmoscope and a non-dilated exam. And it's great that, as you said, these fundus photography techniques and tools are becoming more widely available so that we can get a good look at the fundus. And then we're going to have to learn a lot more about how to interpret those images, right? If we haven't been so confident in our ability to see the fundus and analyze some of the subtle abnormalities that you and your colleagues and our ophthalmology colleagues are more familiar with. So, I appreciate you acknowledging that. And I'm glad to hear that coming down the pipeline, there are going to be some tools to help us there. So, you mentioned some of the things you do at the bedside to try to distinguish between eye and optic nerve. Could you go into those in a little bit more detail here? How do you check the visual fields? For example, some people count fingers, some people wiggle fingers, see when the patient can see. How should we be checking visual fields? And what are some of the other bedside tasks you use to decide this is probably going to end up being in the optic nerve or this seems more like an eye? Dr Newman: Of course. Again, central visual acuity is very important. If somebody is older than fifty, they clearly will need some form of reading glasses. So, keeping a set of plus three glasses from cheapo drugstore in your pocket is very helpful. Have them put on their glasses and have them read an ear card. It's one of the few things you can actually measure and examine. And so that's important. The strongest reflex in the body and I can have it duke it out with the peripheral neurologists if they want to, it's not the knee jerk, it's looking for a relative afferent pupillary defect. Extremely important for neurologists to feel comfortable with that. Remember, you cut an optic nerve, you're not going to have anisocoria. It's not going to cause a big pupil. The pupils are always equal because this is not an efferent problem, it's an afferent problem, an input problem. So basically, if the eye has been injured in the optic nerve and it can't get that information about light back into the brain, well, the endoresfol nuclei, both of them are going to reset at a bigger size. And then when you swing over and shine that light in the good optic nerve, the good eye, then the brain gets all this light and both endoresfol nuclei equally set those pupils back at a smaller size. So that's the test for the relative afferent pupillary defect. When you swing back and forth. Of course, when the light falls on the eye, that's not transmitting light as well to the brain, you're going to see the pupil dilate up. But it's not that that pupil is dilating alone. They both are getting bigger. It's an extremely powerful reflex for a unilateral or asymmetric bilateral optic neuropathy. But what you have to remember, extremely important, is, where does our optic nerve come from? Well, it comes from the retinal ganglion cells. It's the axons of the retinal ganglion cells, which is in the inner retina. And therefore inner retinal disorders such as central retinal artery occlusion, ophthalmic artery occlusion, branch retinal artery occlusion, they will also give a relative afferent pupillary defect because you're affecting the source. And this is extremely important. A retinal detachment will give a relative afferent pupillary defect. So, you can't just assume that it's optic nerve. Luckily for us, those things that also give a relative afferent pupillary defect from a retinal problem cause really bad-looking retinal disease. And you should be able to see it with your direct ophthalmoscope. And if you can't, you definitely will be able to see it with a picture, a photograph, or having an ophthalmologist or optometrist take a look for you. That's really the bedside. You mentioned confrontation visual fields. I still do them, but I am very, very aware that they are not very sensitive. And I have an extremely low threshold to- again, I have something in my office. But if I were a general neurologist, to partner with an eye care specialist who has an automated visual field perimeter in their office because it is much more likely to pick up a deficit. Confrontation fields. Just remember, one eye at a time. Never two eyes at the same time. They overlap with each other. You're going to miss something if you do two eyes open, so one eye at a time. You check their field against your field, so you better be sure your field in that eye is normal. You probably ought to have an automated perimetry test yourself at some point during your career if you're doing that. And remember that the central thirty degrees is subserved by 90% of our fibers neurologically, so really just testing in the four quadrants around fixation within the central 30% is sufficient. You can present fingers, you don't have to wiggle in the periphery unless you want to pick up a retinal detachment. Dr Berkowitz: You mentioned perimetry. You've also mentioned ocular coherence tomography, OCT, other tests. Sometimes we think about it in these cases, is MRI one of the orbits? When do you decide to pursue one or more of those tests based on your history and exam? Dr Newman: So again, it sort of depends on what's available to you, right? Most neurologists don't have a perimeter and don't have an OCT machine. I think if you're worried that you have an optic neuropathy, since we're just speaking about monocular vision loss at this point, again, these are tests that you should get at an office of an eye care specialist if you can. OCT is very helpful specifically in investigating for a macular cause of central vision loss as opposed to an optic nerve cause. It's very, very good at picking up macular problems that would be bad enough to cause a vision problem. In addition, it can give you a look at the thickness of the axons that are about to become the optic nerve. We call it the peripapillary retinal nerve fiber layer. And it actually can look at the thickness of the layer of the retinal ganglion cells without any axons on them in that central area because the axons, the nerve fiber layer, bends away from central vision. So, we can see the best we can see. And remember these are anatomical measurements. So, they will lag, for the ganglion cell layer, three to four weeks behind an injury, and for the retinal nerve fiber, layer usually about six weeks behind an entry. Whereas the functional measurements, such as visual acuity, color vision, visual fields, will be immediate on an injury. So, it's that combination of function and anatomy examination that makes you all-powerful. You're very much helped by the two together and understanding where one will be more helpful than the other. Dr Berkowitz: Let's say we've gotten to the optic nerve as our localization. Many people jump to the assumption it's the optic nerve, it's optic neuritis, because maybe that's the most common diagnosis we learn in medical school. And of course, we have to sometimes, when we're teaching our students or trainees,  say, well, actually, not all optic nerve disease, optic neuritis, we have to remember there's a broader bucket of optic neuropathy. And I remember, probably I didn't hear that term until residency and thought, oh, that's right. I learned optic neuritis. Didn't really learn any of the other causes of optic nerve pathology in medical school. And so, you sort of assume that's the only one. And so you realize, no, optic neuropathy has a differential diagnosis beyond optic neuritis. Neuritis is a common cause. So how do you think about the “what” once you've localized to the optic nerve, how do you think about that? Figure out what the cause of the optic neuropathy is? Dr Newman: Absolutely. And we've been trying to convince neuro-radiologists when they see evidence of optic nerve T2 hyperintensity, that just means damage to the optic nerve from any cause. It's just old damage, and they should not put in their read consistent with optic neuritis. But that's a pet peeve. Anyway, yes, the piece of tissue called the optic nerve can be affected by any category of pathophysiology of disease. And I always suggest that you run your categories in your head so you don't leave one out. Some are going to be more common to be bilateral involvement like toxic or metabolic causes. Others will be more likely unilateral. And so, you just run those guys. So, in my mind, my categories always are compressive-slash-infiltrative, which can be neoplastic or non-neoplastic. For example, an ophthalmic artery aneurysm pressing on an optic nerve, or a thyroid, an enlarged thyroid eye muscle pressing on the optic nerve. So, I have compressive infiltrative, which could be neoplastic or not neoplastic. I have inflammatory, which can be infectious. Some of the ones that can involve the optic nerve are syphilis, cat scratch disease. Or noninfectious, and these are usually your autoimmune such as idiopathic optic neuritis associated with multiple sclerosis, or MOG, or NMO, or even sarcoidosis and inflammation. Next category for me would be vascular, and you can have arterial versus venous in the optic nerve, probably all arterial if we're talking about causes of optic neuropathy. Or you could have arteritic versus nonarteritic with the vascular, the arteritic usually being giant cell arteritis. And the way the optic nerve circulation is, you can have an anterior ischemic optic neuropathy or a posterior ischemic optic neuropathy defined by the presence of disc edema suggesting it's anterior, the front of the optic nerve, or not, suggesting that it's retrobulbar or posterior optic nerve. So what category am I- we mentioned toxic, metabolic nutritional. And there are many causes in those categories of optic neuropathy, usually bilateral. You can have degenerative or inherited. And there are causes of inherited optic neuropathies such as Leber hereditary optic neuropathy and dominant optic atrophy. And then there's a group I call the mechanical optic neuropathies. The obvious one is traumatic, and that can happen in any piece of tissue. And then the other two relate to the particular anatomy of the eyeball and the optic nerve, and the fact that the optic nerve is a card-carrying member of the central nervous system. So, it's not really a nerve by the way, it's a tract. Think about it. Anyway, white matter tract. It is covered by the same fluid and meninges that the rest of the brain. So, what mechanically can happen? Well, you could have an elevated intraocular pressure where that nerve inserts. That's called glaucoma, and that would affect the front of the optic nerve. Or you can have elevated intracranial pressure. And if that's transmitted along the optic nerve, it can make the front of the optic nerve swell. And we call that specifically papilledema, optic disk edema due specifically to raised intracranial pressure. We actually even can have low intraocular pressure cause something called hypotony, and that can actually even give an optic neuropathy the swelling of the optic nerve. So, these are the mechanical. And if you were to just take that list and use it for any piece of tissue anywhere, like the heart or the kidney, you can come up with your own mechanical categories for those, like pericarditis or something like that. And then all those other categories would fit. But of course, the specific causes within that pathophysiology are going to be different based on the piece of tissue that you have. In this case, the optic nerve. Dr Berkowitz: In our final moments here, we've talked a lot about the approach to monocular visual loss. I think most neurologists, once we find a visual field defect, we breathe a sigh of relief that we know we're in our home territory here, somewhere in the visual task base that we've studied very well. I'm not trying to distinguish ocular causes amongst themselves or ocular from optic nerve, which can be very challenging at the bedside. But one topic you cover in your article, which I realized I don't really have a great approach to, is transient binocular visual loss. Briefly here, since we're running out of time, what's your approach to transient binocular visual loss?  Dr Newman: We assume with transient binocular vision loss that we are not dealing with a different experience in each eye, because if you have a different experience in each eye, then you're dealing with bilateral eyeball or optic nerve. But if you're having the same experience in the two eyes, it's equal in the two eyes, then you're located. You're located, usually, retro chiasmally, or even chiasm if you have pituitary apoplexy or something. So, all of these things require imaging, and I want to take one minute to talk about that. If you are sure that you have monocular vision loss, please don't get a brain MRI without contrast. It's really useless. Get a orbital MRI with contrast and fat suppression techniques if you really want to look at the optic nerve. Now, let's say you you're convinced that this is chiasmal or retrochiasmal. Well then, we all know we want to get a brain MRI---again, with and without contrast---to look specifically where we could see something. And so, if it's persistent and you have a homonymous hemianopia, it's easy, you know where to look. Be careful though, optic track can fool you. It's such a small little piece, you may miss it on the MRI, especially in someone with MS. So really look hard. There's very few things that are homonymous hemianopias MRI negative. It may just be that you didn't look carefully enough. And as far as the transient binocular vision loss, again, remember, even if it's persistent, it has to be equal vision in the two eyes. If there's inequality, then you have a superimposed anterior visual pathway problem, meaning in front of the chiasm on the side that's worse. The most common cause of transient binocular vision loss would be a form of migraine. The visual aura of migraine usually is a positive phenomenon, but sometimes you can have a homonymous hemianopic persistent defect that then ebbs and flows and goes away. Usually there's buildup, lasts maybe fifteen minutes and then it goes away, not always followed by a headache. Other things to think of would be transient ischemic attack in the vertebra Basler system, either a homonymous hemianopia or cerebral blindness, what we call cortical blindness. It can be any degree of vision loss, complete or any degree, as long as the two eyes are equal. That should last only minutes. It should be maximum at onset. There should be no buildup the way migraine has it. And it should be gone within less than ten minutes, typically. After fifteen, that's really pushing it. And then you could have seizures. Seizures can actually be the aura of a seizure, the actual ictal phenomenon of a seizure, or a postictal, almost like a todd's paralysis after a seizure. These events are typically bright colors and flashing, and they last usually seconds or just a couple of minutes at most. So, you can probably differentiate them. And then there are the more- less common but more interesting things like hyperglycemia, non-ketonic hyperglycemia can give you transient vision loss from cerebral origin, and other less common things like that. Dr Berkowitz: Fantastic. Although we've talked about many pearls of clinical wisdom here with you today, Dr Newman, this is only a fraction of what we can find in your article with Dr Biousse. We focused here on monocular visual loss and a little bit at the end here on binocular visual loss, transient binocular visual loss. But thank you very much for your article, and thank you very much for taking the time to speak with us today. Again, today I've been interviewing Dr Nancy Newman about her article with Dr Valerie Biousse on the approach to visual loss, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum audio episodes from this and other issues. Thank you so much to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Autonomy and self-determination for all individuals cannot be realized and sustained unless true within every person. Enslavement and dehumanization remain true of citizens of imperial nations so long as they remain true for colonized peoples. This week's episode explores the contradictions between stated commitments to human rights and actions in Western and post-colonial societies. Host Sahar Aziz addresses these issues with Emory University School of Law Professor Abdullahi Ahmed An-Na'im.Support the Center for Security, Race, and Rights by following us and making a donation: Donate: https://give.rutgersfoundation.org/csrr-support/20046.html Follow us on Twitter: https://twitter.com/rucsrr Follow us on Instagram: https://instagram.com/rutgerscsrr Follow us on Facebook: https://facebook.com/rucsrr Follow us on TikTok: https://tiktok.com/rucsrr Subscribe to our Newsletter: https://csrr.rutgers.edu/newsroom/sign-up-for-newsletter/

Tracey Henry, MD, MPH, MS, Associate Professor of Medicine, Division of General Medicine, EMPACT Program Director, Thread Director – Diversity, Equity, Inclusion and Racial Advocacy, Emory University School of MedicineCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: ⁠https://forms.office.com/r/LLyExPGiFp ⁠ (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: April 8, 2025End Date: April 8, 2026

Tracey Henry, MD, MPH, MS, Associate Professor of Medicine, Division of General Medicine, EMPACT Program Director, Thread Director – Diversity, Equity, Inclusion and Racial Advocacy, Emory University School of MedicineCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: ⁠https://forms.office.com/r/LLyExPGiFp ⁠ (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: April 8, 2025End Date: April 8, 2026

Luis Manuel Tumialán is a Professor of Neurosurgery at the Barrow Neurological Institute specializing in minimally invasive spinal surgery. He graduated from Georgetown University School of Medicine, completed his internship at the Naval Medical Center in San Diego. Dr. Tumialán completed additional training in undersea medicine in Groton Connecticut and Navy Dive School in Panama City, Florida. Upon completion of his operational training, he served as the Diving Medical Officer assigned to Naval Special Warfare Unit One in Guam during the Global War on Terror in the aftermath of September 11th, 2001. He received a Naval and Marine Corps Commendation Medal for service in support of Operation Enduring Freedom in Southeast Asia and a Navy Humanitarian Medal for the search and maritime rescue of a foreign national.Once he returned to the mainland, Dr. Tumialán completed his neurosurgery training at Emory University School of Medicine and returned to the Naval Medical Center in San Diego. He joined Barrow Brain and Spine in 2010 where he serves as the director of minimally invasive spine surgery. Dr. Tumialán's main interests are in minimally invasive spinal surgery and motion preservation surgery as well as developing techniques for the next generation of spinal surgery.

Delligatti v. United States concerned whether a crime that requires proof of bodily injury or death, but can be committed by failing to take action, has as an element the use, attempted use, or threatened use of physical force.Known by some as the "non-violent murder case" Delligatti ties into a larger conversation on the way "violent"/"use-of-force" crimes are defined categorically rather than on a solely case-by-case basis.Oral argument was heard by the Supreme Court in early November 2024, and on March 21, 2025, a 7-2 Court affirmed the ruling of the Second Circuit below against Delligatti.Join us for a discussion of this decision and its possible ramifications.Featuring:Matthew P. Cavedon, Robert Pool Fellow in Law and Religion, Emory University School of Law

Host Tia Mitchell talks with Fred Smith Jr., a professor at Emory University School of Law, about the tensions between the Trump administration and the courts. Then, Greg Bluestein updates us from the Gold Dome on a long-debated religious liberty measure. Have a question or comment for the show? Call the 24-hour Politically Georgia Podcast Hotline at 770-810-5297. We'll play back your question and answer it during our next listener mailbag segment. Listen and subscribe to our podcast for free at Apple Podcasts, Spotify, or wherever you listen to podcasts. You can also tell your smart speaker to “play Politically Georgia podcast.”   Learn more about your ad choices. Visit megaphone.fm/adchoices

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy. JAMA Cardiology 2025. Discussion by:Guest: Michael J. Blaha, MD, MPHProfessor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for theJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease2. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine. Discussion by:Guest:Amreen Syed, DO Resident– Family Medicine Residency ProgramJefferson Health – Abington3. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis Journal of Allergy and Clinical Immunology in Practice3. Discussion by:Guest:Michelle Buchbinder, MDResident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Send us a text about this episode.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Join Dr. Stephanie and Dr. Saulnier as they discuss her presentation on broadening the autism spectrum at the Converge Autism Summit. They will discuss:The key features of autismHow Autism symptoms are expressed differently in male and femaleThe role of racial, ethnic, and socioeconomic disparities in misdiagnosis of autismCommon overlaps and differential diagnosisWhat if someone being assessed doesn't want to be on the spectrum? What do clinicians need to know?Bio:Dr. Saulnier obtained her doctorate in Clinical Psychology from the University of Connecticut. She trained and worked at the Yale Child Study Center's Autism Program for nearly a decade before relocating to Emory University School of Medicine and the Marcus Autism Center in Atlanta, GA, where she directed a large-scale clinical research program. In 2018, she opened her own company, Neurodevelopmental Assessment & Consulting Services, where she specializes in diagnostic assessment, as well as teaching and training for autism spectrum and related disorders. Dr. Saulnier has published over 50 articles, written two books, and she is an author on the Vineland Adaptive Behavior Scales, Third Edition.Looking for Assessment in GA? https://www.psychologytoday.com/us/therapists/neurodevelopmental-assessment-consulting-svc-decatur-ga/409874

When it comes to the bird flu, you are probably panicking about the wrong things! Understand the bird flu's impact on wild birds, chickens, cows, cats, your grocery bill and whether or not your health is at risk. Dr. Seema Lakdawala, a molecular virologist from Emory University, is here to calm your fears with the latest bird flu news and help you better understand how the virus will impact you. She breaks down everything you need to know — what the H5N1 virus is and how it spreads, if the bird flu will become a pandemic, the difference between avian influenza and the seasonal flu, the bird flu symptoms in humans, how bird flu is affecting chickens, ducks and cows, how infections in wild birds are causing the spread of the virus and how you can best protect yourself from infection. Understand the impact vaccines will have against the virus and why we need to offer the vaccine to our poultry farmers and veterinarians, how your cat could be at risk for the bird flu virus and why infected chickens are causing high egg prices and egg shortages. And be sure to stay tuned until the end of the video! Mayim shows you a few egg substitutes for baking to save you money and precious eggs while we combat this virus and sky-high egg prices! Current CDC Bird Flu Stats: https://www.cdc.gov/bird-flu/situation-summary/index.html Learn more about Emory University School of Medicine's Department of Microbiology and Immunology: https://med.emory.edu/departments/microbiology-immunology/index.html BialikBreakdown.comYouTube.com/mayimbialik

Emory University School of Law professor Ifeoma Ajunwa discusses her 2023 book, “The Quantified Worker: Law and Technology in the Modern Workplace,” which argues the workforce science of today is more of a threat than an aid to employees. Ajunwa was introduced by Professor Danielle Citron. The event was sponsored by the LawTech Center. (University of Virginia School of Law, Feb. 28, 2025)

Speaker: Professor Margo Bagley, Emory University School of Law Abstract: 2024 was a year for multilateral IP like no other. WIPO Member states adopted two new treaties last year: the WIPO Treaty on IP, Genetic Resources and Associated Traditional Knowledge and the Riyadh Design Law Treaty. Both were groundbreaking in their mention of one or more of genetic resources, traditional knowledge, traditional cultural expressions, and indigenous peoples and local communities, none of which are standard IP topics and all of which have been controversial additions to the normative work at WIPO. Moreover, both treaties address disclosure of origin for one or more of these controversial areas, another first for a WIPO treaty. I will discuss how these two treaties came to fruition and their ramifications for future multilateral IP treaty-making.Biography: Margo A. Bagley is Asa Griggs Candler Professor of Law at Emory University School of Law. She returned to Emory in 2016 after ten years at the University of Virginia School of Law, where she held the Hardy Cross Dillard chair. She was the Hieken Visiting Professor in Patent Law at Harvard Law School in Fall 2022. Her scholarship focuses on comparative issues relating to patents and biotechnology, pharmaceuticals and access to medicines, and IP and social justice issues. Professor Bagley served on two National Academies Committees on IP matters, is a technical expert to the African Union in World Intellectual Property Organization (WIPO) matters, and has served as a consultant to several United Nations organizations. She has served as a US Department of Commerce Commercial Law Development Program advisor and currently serves as a member of the U.S. DARPA ELSI Team for the BRACE project. She is an elected member of the American Law Institute and a faculty lecturer with the Munich Intellectual Property Law Center at the Max Planck Institute in Germany, and also has taught patent related courses in China, Cuba, Israel, and Singapore. She has published numerous articles, book chapters, and monographs as well as two books with co-authors with a third on the way. She is registered to practice before the U.S. Patent and Trademark Office, practiced patent law with both Finnegan, Henderson, Farabow, Garrett & Dunner, and Smith, Gambrell and Russell, and has been an expert witness in several patent cases. A chemical engineer by training, Professor Bagley worked in industry for several years before attending law school at Emory where she was a Woodruff Fellow. She is a co-inventor on patents on peanut butter and bedding technology. For more information see: https://www.cipil.law.cam.ac.uk/seminars-and-events/cipil-seminars

In this episode of the PRS Global Open Keynotes podcast, Dr. Eric Wagner discusses the pros and cons of joint replacement and joint fusion for interphalangeal joint arthritis.   This episode discusses the following PRS Global Open article: “Utilization of Interphalangeal Joint Arthroplasty and Arthrodesis in the United States From 2010 to 2019” by Erica L. Smearman, Anthony L. Karzon, Hayden L. Cooke, Zaamin B. Hussain, Musab Gulzar, Nina Suh, Michael B. Gottschalk and Eric R. Wagner. Read it for free on PRSGlobalOpen.com: https://journals.lww.com/prsgo/fulltext/2025/01000/utilization_of_interphalangeal_joint_arthroplasty.54.aspx Dr. Eric Wagner is an Associate Professor in the Department of Orthopaedics at Emory University School of Medicine in Atlanta, Georgia. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Plastic Surgery at the University of Sydney in Australia. #PRSGlobalOpen; #KeynotesPodcast; #PlasticSurgery; Plastic and Reconstructive Surgery- Global Open

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Brain Function Outcomes of Recent and Lifetime Cannabis Use. JAMA Network Open 2025. Discussion by: Guest:Maija Adourian, DOResident– Family Medicine Residency Program Jefferson Health – Abington2. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. New England Journal of Medicine. Discussion by:Guest:Christopher M. Kramer, MD George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine Chief of the Cardiovascular Division UVA Health3. Screening for Osteoporosis to Prevent FracturesUS Preventive Services Task Force Recommendation Statement. Discussion by:Guest: Anupriya Grover-Wenk, DOFaculty– Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Everyone has felt overwhelmed by loud noises, bright lights, or strong smells — but for people with schizophrenia, sensory overload can be constant and intense. Sensory processing dysfunction can make everyday sights, sounds, and touches feel overwhelming, leading to a phenomenon called “sensory flooding.” It can also make it harder to filter out background noise, identify sensory sources, and focus on tasks — sometimes even contributing to symptoms of psychosis like hallucinations and delusions. Hosts Rachel Star Withers and Gabe Howard explore how schizophrenia affects the senses and what this means for daily life. They're joined by Dr. Ray Kotwicki, a psychiatrist and Chief Medical Officer at Hightop Health, who shares expert insights into the science behind sensory processing challenges and how to manage them. Tune in for a fascinating look at the intersection of schizophrenia, sensory overload, and mental health! To learn more -- or read the transcript -- please visit the official episode page. Our guest, Dr. Ray Kotwicki, MD, MPH, DFAPA, is a psychiatrist and the Chief Medical Officer at Hightop Health.  Dr. Kotwicki trained as a Department of Energy Fellow and was a Medical Scholar at the University of Wisconsin Medical School. He completed post-graduate training at Harvard Medical School, the Boston University School of Medicine, and Emory University, where he earned a Master in Public Health degree in Health Policy and Management. He remains a full professor on the adjunctive faculty at both the Emory University School of Medicine as well as the Rollins School of Public Health. Kotwicki has presented more than 425 invited lectures, symposia, and seminars to thousands of attendees. He is recognized as a trusted national expert and renowned speaker on current issues in psychiatry, mental health, professionalism, and wellness. Our host, Rachel Star Withers, creates videos documenting her schizophrenia, ways to manage and let others like her know they are not alone and can still live an amazing life. She has written Lil Broken Star: Understanding Schizophrenia for Kids and a tool for schizophrenics, To See in the Dark: Hallucination and Delusion Journal. Fun Fact: She has wrestled alligators. To learn more about Rachel, please visit her website, RachelStarLive.com. Out co-host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To learn more about Gabe, please visit his website, gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dean's Chat hosts,  Dr. Jeffrey Jensen  and Dr. Johanna Richey, are  joined by Dr. Wayne Bakotic and Dr. Warren Joseph on today's show discussing their careers and their specialties that overlap in dematopathology and infectious disease.   Discussions range from PCR testing for both fungus and bacteria, to their careers, their influence in the podiatric community, the advancement of AI in medicine, and relationship among specialists. A wonderful discussion, you'll wonder where 45 minutes went! Dr. Wayne L. Bakotic began his medical training with early acceptance into Barry University School of Podiatric Medicine where he completed his biomedical sciences degree through his podiatric medical studies. Prior to graduation, Dr. Bakotic left his podiatry training to initiate studies in Osteopathic medicine at Nova Southeastern University College of Osteopathic Medicine. It was, however, his time at Barry University which set the stage for his interest in podiatric pathology. After graduating with honors and completing his Doctor of Osteopathy in 1998, Dr. Bakotic continued his journey at Emory University School of Medicine where he gained training in anatomic and clinical pathology. He remained at Emory University to complete fellowship training in surgical pathology, Cytopathology and Dermatopathology, gaining board certification in anatomic pathology, clinical pathology, and Dermatopathology. In 2008 Dr. Bakotic co-founded Bako Diagnostics in Alpharetta, GA with the goal of serving the podiatric medical community and where he continues in the role of Chief Medical Officer.  Dr. Joseph a leader in our profession and a member of the Podiatric Hall of Fame. Dr. Joseph is a specialist in the treatment of lower extremity infectious diseases. He received his podiatric degree from the Wm. Scholl College of Podiatric Medicine in Chicago. Dr Joseph completed his postgraduate training in podiatric medicine/surgery at St. Joseph's Hospital, and a fellowship in infectious diseases at Hahnemann University School of Medicine, both in Philadelphia. He is currently an Adjunct Clinical Professor at the Arizona College of Podiatric Medicine at Midwestern University in Glendale, AZ. Dr. Joseph is a fellow of the Infectious Diseases Society of America and is an author of the IDSA Diabetic Foot Infection Guidelines. He is also certified by the American Board of Podiatric Medicine and currently serves as Editor of the Journal of the American Podiatric Medical Association. Dr Joseph lectures extensively and his presentations have focused on the treatment of bacterial and fungal infections of the lower extremity. He has authored close to 100 publications in the field of lower extremity infections. A fun discussion not only on Dr. Joseph's career but a look into his eclectic interests as well! Enjoy! https://bakodx.com/ https://bmef.org/ www.explorepodmed.org www.apma.org https://podiatrist2be.com/ https://higherlearninghub.com/    

Join me for a conversation as we celebrate the most important love of all—self-love!  I'm thrilled to welcome Dr. Mena.Dr. Nina Joy Mena, known as Dr. NJoy, is an Atlanta-based community psychiatrist, author, and motivational speaker, committed to reducing mental health stigma in the Black community. A wife and mother of three, she is double board-certified in General Psychiatry and Child & Adolescent Psychiatry, with licenses in ten states.Dr. NJoy serves as Chief Medical Officer at CHRIS 180 and has held academic roles at Morehouse and Emory University School of Medicine. As founder of NJoy LIFE LLC and host of the Journey to Joy Live podcast, she champions mental wellness, resilience, and joy.Her journal, NJoyNAL: Nurturing Authentic Living, released in 2024, highlights holistic self-care and growth. An avid runner, Dr. NJoy has completed 36 half marathons and 9 full marathons, using running as therapy. A proud member of Alpha Kappa Alpha Sorority, Inc., she embodies leadership and service.Connect with Dr. Mena:Facebook: @NJoy LIFEInstagram: @Dr.NJoy.LifeYoutube: @DrNJoyLifeMDTik Tok: @Dr.NJoy.Life

Observations from practice and data analysis have shown that the duration of mechanical thrombectomy procedures are a strong predictor of outcome even with successful procedures. A large multicenter study was conducted which gives insight into choices between catheter types, and strategic decisions to be made during prolonged procedures. Dr Felipe C. Albuquerque, Editor-in-Chief of JNIS, interviews Dr. Ali Alawieh¹ and Dr. Alejandro Spiotta²,  two authors of the paper:  Prolonged intracranial catheter dwell time exacerbates penumbral stress and worsens stroke thrombectomy outcomes   1. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA 2. Med Univ S Carolina, Charleston, South Carolina, USA   Please subscribe to the JNIS podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/4aZmlpT) or Spotify (https://spoti.fi/3UKhGT5). We'd love to hear your feedback on social media - @JNIS_BMJ.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Antidiabetic Medication – Diabetes Care. Discussion by: Guest:James Flory, M.D.Associate Professorin the Weill Cornell Medical College Associate Attending at the Memorial Sloan Kettering Cancer Center.2. Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years – BMJ Medicine. Discussion by:Guest:Kimberly Alfonso, MD, Resident– Family Medicine Residency ProgramJefferson Health – Abington3. Fluoride Exposure and Children's IQ Scores A Systematic Review and Meta-Analysis . JAMA Pediatrics 2024. Discussion by: Guest:Elyssa Heisey, DOResident– Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Send us a text about this episode.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Acute kidney injury is a frequent complication of critical illness, and a subgroup of these patients will require renal replacement therapy. In this episode. Dr. Sergio Zanotti discusses optimizing renal replacement therapy in the ICU. He is joined by Dr. Michael J. Connor, Jr., a practicing intensivist and nephrologist. He is a professor and senior physician of critical care medicine and nephrology at the Divisions of Pulmonary, Allergy, Critical Care, & Sleep Medicine and Renal Medicine at Emory University School of Medicine. In addition, he is the director of critical care nephrology at the Emory Critical Care Center at Grady Memorial Hospital. Additional resources: Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Wald R, et al. Intensive Care Med 2022: https://pubmed.ncbi.nlm.nih.gov/36066597/ Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. AKIKI Study Group. N Engl J Med 2016: https://pubmed.ncbi.nlm.nih.gov/27181456/ Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients with Acute Kidney Injury. ELAIN Trial. JAMA 2016: https://pubmed.ncbi.nlm.nih.gov/27209269/ Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. IDEAL-ICU Investigators. N Eng J Med 2018: https://pubmed.ncbi.nlm.nih.gov/30304656/ Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. STARRT-AKI Investigators. N Engl J Med 2020: https://pubmed.ncbi.nlm.nih.gov/32668114/ Comparison of two delayed strategies for renal therapy initiation for severe acute kidney injury. AKIKI 2 Trial. Lancet 2021: https://pubmed.ncbi.nlm.nih.gov/33812488/ Books and Music mentioned in this episode: The Invisible Life of Addie LaRue. By V.E. Schwab: The Invisible-Life-Addie-LaRue Moon Music. By Coldplay: Moon-Music-Coldplay

Tweetorials: Bridging Connections in Medical Education with Nano Learning (EP.39)  With Catherine S.W. Albin, MD How can we distill complex medical concepts into bite-sized, engaging content? What role does social media play in revolutionizing education? Can nano learning connect learners and foster a community of shared knowledge? Join host Stacy Craft and guest Dr. Catherine Albin, a neurointensivist and clinical educator at Emory University School of Medicine to delve into the innovative world of "tweetorials" and nano-learning, exploring how these bite-sized educational tools are transforming medical education and all education. Special Thanks to Dr. Andrea Leep Hunderfund Questions? Feedback? Ideas? Contact us at edufi@mayo.edu Audio Editing: Celina Bertoncini Additional Resources: Albin, C. S., Ma, T., Pucci, G. F., Zelikovich, A. S., Lawson, E. C., Dhruva, N., ... & Jones Jr, L. K. (2024). Education research: making a tweetorial fly: features of educational social media posts associated with high sharing and engagement. Neurology® Education, 3(4), e200160.  Anthony C. Breu, Hannah R. Abrams, Kimberly D. Manning, Avraham Z. Cooper; Tweetorials for Medical Educators. J Grad Med Educ 1 October 2021; 13 (5): 723–725. doi: https://doi.org/10.4300/JGME-D-21-00767.1 Luzón, M. J. (2024). “Come along for a tweetorial!”: Recontextualization strategies in biomedical publication-promoting tweetorials. English for Specific Purposes, 74, 132-148. Logan, M. S., & O'Banion, L. A. (2022). Webinars, podcasts, Tweetorials, oh my!. Journal of Vascular Surgery, 76(4), 853-854. Video: CardioNerds Academy Tweetorials Bootcamp with Dr. Tony Breu  

In his second term in office, President Donald Trump has already taken sweeping measures on immigration, the environment, the U.S. military, and the structure of the federal government.With so many executive orders, policy changes, and novel actions, it's easy to wonder, “What just happened?” In this podcast mini-series we help to answer exactly that question.On each episode of “What Just Happened,” we'll talk with leading experts, from former government officials to professors – the people who understand how government works from the inside and have studied the issues for years. They will explain the legal background and implications of how the Trump administration's actions affect how the U.S. government operates in Washington, across the country, and around the world. This is not a political podcast. We are explaining the meaning and consequences of policy changes that may not be immediately apparent. Any opinions expressed are those of the speaker.Today, we will focus on President Trump's potential deployment of the U.S. military. Trump has said that he intends to use more military resources to support border and immigration enforcement. Joining the show is Mark Nevitt. Mark is a professor at Emory University School of Law. Mark was previously a Commander in the Navy, where he was a tactical aviator and a JAG officer.This mini-series is co-hosted by David Aaron, Tess Bridgeman, and Ryan Goodman. Show Notes: David Aaron (LinkedIn – X)Tess Bridgeman (LinkedIn – BlueSky – X)Ryan Goodman (Bluesky – LinkedIn) Mark P. Nevitt (Bluesky – LinkedIn – X) Mark's Just Security article “What Just Happened: Unpacking Exec Order on National Emergency at the Southern Border” Just Security's coverage of the Trump administration's executive actions Music: “Broken” by David Bullard from Uppbeat: https://uppbeat.io/t/david-bullard/broken (License code: OSC7K3LCPSGXISVI)

Value-based care is a team effort, and nurses play a crucial role in coordinating care to achieve better and more efficient patient outcomes. Jacqueline Nikpour, Assistant Professor at the Emory University School of Nursing, and Kathy Samhammer, LPN at Cedar Ridge Family Medicine, join us to discuss the role of nurses in primary care, and how practices can maximize nurses' contributions in the shift towards value-based care. Kathy's role includes managing chronic conditions and preventing hospital readmissions, and she discusses the importance of ongoing, personalized communication with patients, especially after ER visits. This approach has led to better patient engagement and satisfaction, which is crucial for improving health outcomes. As Kathy demonstrates, expanding the role of nurses in value-based care is critical, but Jacqueline also notes the challenges in this expansion, including payment and recognition of nurses' value. By addressing these challenges and better integrating nurses in patient care teams, we can ensure better care coordination and a more patient-centered health care system. Read Jacqueline's article in Health Affairs: To Improve Outcomes Under CMS' ‘Making Care Primary', Focus On Registered Nurses Connect with us at acoshow@aledade.com or visit the Aledade Newsroom

2024 was a very active year on research in antimicrobial resistance, highlighted by an impactful and high level political declaration to combat antimicrobial resistance by the United Nations. In this episode, trainees from NIH-funded training program (T32) on antimicrobial resistance will help me discuss the most relevant research on the field in the year 2024. Welcome to editors in conversation! Topics discussed: The best papers of 2024 in gram-positive, gram-negative, mycobacterial and parasite resistance Guests: Nathalie Chen: University of Pittsburgh, Pittsburgh, PA Alex Kang: Houston Methodist Research Institute, Houston, TX Nathan Rabbe: University of Pittsburgh, Pittsburgh, PA Taylor Blackburn: Emory University, Atlanta, GA Jacon McPherson: University of Houston, Houston, TX. Harrison Lee, MD: Associate Chief of Epidemiology and Microbial Genomics, Professor of Medicine and Epidemiology, Director, Center for Genomic Epidemiology, Director, T32 AMR, U of Pittsburgh William Shafer, PhD: Professor, Department of Microbiology and Immunology, Emory University School of Medicine, Co-Director, Emory Antibiotic Resistance Center. Director T32 AMR, Emory University This episode is brought to you by the Antimicrobial Agents and Chemotherapy Journal.  Visit asm.org/aac to browse issues and/or submit a manuscript. If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/joinasm to sign up.

Drs. Jensen and Richey are so excited to welcome Dr. Chandler Ligas to Dean's Chat - as he is a young emerging leader in the field of podiatric medicine and surgery.  Dr. Ligas currently works in Oakwood Georgia and is faculty with the Emory University School of Medicine Residency Program.  Dr. Ligas' interest for podiatric medicine developed after a soccer injury and a conversation with his cousin (and now business partner Dr. Thomas Brosky) He completed his undergraduate degree with a Bachelors of Arts in Biology/Premed at Pfeiffer University in North Carolina. He then went on to the Kent State College of Podiatric Medicine where he received his Doctorate of Podiatric Medicine Degree. He went to Emory University to complete his three-year surgical residency training and listen in as he discusses his recent fellowship with the Silicon Valley Reconstructive Foot and Ankle Fellowship on the West Coast in Northern California.  Join us as we have an in-depth discussion about fellowship training, The value that it provides for anyone wanting to finesse their clinical skills, as well as advanced their career by providing them with a network and opportunities including potential earlier board certification. Dr. Ligas is full of excellent tips and suggestions about what questions residents can ask themselves as they are considering opportunities for fellowship. Listen as he discusses the considerations and questions he had as a resident and how it helped shape his decision. Dr. Ligas is a natural leader and has received several leadership awards, including the Michael L Stone award, Thomas E Melito scholarship as well as the APSA National Student of the Year award. He continues to lead our profession now as an Attending faculty and shares his insights about where the opportunities lie in the future. He discusses some of his early mentors and the programs that helped inspire him to lead such as the S.T.E.P.S. program. He has been heavily involved in research and is an active member with multiple professional organizations, including the Podiatry Institute, the STEPS Foundation, and American College of Foot and Ankle Surgeons as a member of the scientific literature review committee. He has published multiple papers and delivered several lectures across the country. Join us as we discuss the passion for education and research and dive into the many ways people can get involved.  https://med.emory.edu/departments/orthopaedics/education/residency/podiatry/index.html https://podiatryinstitute.com/ https://supportcmc.com/education/steps/ https://www.acfas.org/ https://www.abfas.org/residents https://www.apma.org/ 

How should podcasters talk about crime in a way that informs the public while respecting the legal process and the rights of everyone involved? This question has taken on unprecedented importance now that anyone can become a citizen journalist by using nothing more expensive than a computer and cellphone. Join us for a conversation exploring the issue with two veteran true crime podcasters, moderated by a scholar of criminal law.Featuring:Alice Shih LaCour, Partner, Hilgers Graben PLLC; Co-Host, The Prosecutors PodcastDavid Oscar Markus, Partner, Markus/Moss LLP; Host, For the Defense Podcast(Moderator) Matthew P. Cavedon, Robert Pool Fellow in Law and Religion, Emory University School of Law

In Barnes v. Felix the Supreme Court is set to address a circuit split concerning the context courts should consider when evaluating an excessive force claim brought under the Fourth Amendment.Is the correct rubric the "moment of threat" doctrine (which was applied by the Fifth Circuit here and has been adopted by several other circuits including the Second, Fourth, and Eighth), which considers only whether there was imminent danger creating a reasonable fear for one's life in the immediate moment(s) preceding the use of force? Alternately, should a court consider the "totality of circumstances" (along the lines of the precedent of the First, Third, Sixth, Seventh, Ninth, Tenth, Eleventh, and D.C. Circuits) when assessing if it was a justified use of force?Join us for a Courthouse Steps program where we will break down and analyze how oral argument went before the Court.Featuring:Matthew P. Cavedon, Robert Pool Fellow in Law and Religion, Emory University School of Law

n this episode, we're honored to welcome Dr. Maya McCarthy, a trailblazing pediatric hospitalist and Assistant Professor at Emory University School of Medicine. With over a decade of experience in pediatrics, including leadership roles at Morehouse and UT Health, Dr. McCarthy has dedicated her career to transforming the lives of children and their families. Beyond her impressive professional accomplishments, Dr. McCarthy's personal journey is equally remarkable. From navigating her own fertility challenges to founding The Doctor's Womb, she has turned her struggles into a mission to support and inspire others. Join us as Dr. McCarthy shares her story of resilience, hope, and how she's creating a space where no woman feels alone on their fertility journey.

This episode of Going anti-Viral features an IAS–USA Dialogue titled "Latest Update on Urgent Viral Outbreaks," a panel discussion held on January 15, 2025. This IAS-USA Dialogue is a must listen as our distinguished panel of infectious diseases experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, this Dialogue brings together world-class experts Yvonne Maldonado, MD, Peter Chin-Hong, MD, and Jason Zucker, MD, to discuss the latest news on urgent and emerging viral outbreaks, including mpox, avian flu (H5N1), respiratory syncytial virus (RSV), measles, human metapneumovirus, and COVID-19/long COVID.The panel also reflects on the alarming erosion of public trust in public health experts, which has been compounded by misinformation and the long-term effects of the COVID-19 pandemic. 0:00 – Introduction 2:27 – Update on mpox including treatment options11:09 – Discussion of avian flu (H5N1), influenza, and vaccination in human and animals27:36 – Impact of avian flu (H5N1) on dairy and other agriculture industries and the role of public health in supporting the economy32:47 – Impact of recent study on Tamiflu in treatment recommendations and discussion of Biloxivir37:37 – Update on COVID-19 – vaccination, treatment with Paxlovid, other treatment options, and long COVID48:27 – Recent updates on respiratory syncytial virus (RSV) and vaccination 52:03 – Discussion of human metapneumovirus54:25 –Impact of misinformation on the reduction in measles vaccinations and the health risks of measles to the population at large 59:54 – Concluding remarks__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

In episode 221 of America Adapts, we're hosting some of the world's leading adaptation experts (and previous podcast guests) to make climate predictions for  2025! From the growing impacts of wildfires reshaping communities, extreme heat, adaptation technology, to the potential massive shifts in climate policy under a new presidential administration, this year promises to be a turning point. Join us as we explore the trends, innovations, and strategies that will define climate adaptation in the year to come. You won't want to miss what these experts have to say about the future of climate adaptation! Experts in this Episode: Dr. Jesse Keenan – Favrot II Associate Professor of Sustainable Real Estate and Urban Planning, Director, Center on Climate Change and Urbanism at Tulane University Dr. AR Siders – Director of the Gerard J. Mangone Climate Change Science and Policy Hub at the University of Delaware Shaun Martin – Vice President, Adaptation and Resilience, World Wildlife Fund Dr. Shalini Vajjhala – Executive Director of PRE Collective Mark Nevitt – Associate Professor of Law at the Emory University School of Law Dr. Carolyn Kousky – Founder Insurance for Good Beth Gibbons – Director of the Resiliency Office Washtenaw County, Michigan Dr. Ladd Keith – Associate professor in the School of Landscape Architecture and Planning, University of Arizona Emilie Mazzacurati – Co-Founder of Tailwind Battelle's ICR25 ICR25 brings together the world's brightest minds to solve the resilience challenge. This year's theme, “Partner, Accelerate, Launch,” highlights the critical need for innovative solutions to reach commercialization and impact resilience. Submit an abstract here:  Abstracts https://www.battelle.org/conferences/icr Register here: https://www.battelle.org/conferences/icr/technical-program-registration Check out the America Adapts Media Kit here! Subscribe to the America Adapts newsletter here. Donate to America Adapts Listen to America Adapts on your favorite app here!   Facebook, Linkedin and Twitter: https://www.facebook.com/americaadapts/ @usaadapts https://www.linkedin.com/in/doug-parsons-america-adapts/ Links in this episode: US National Adaptation and Resilience Planning Strategy 2025 https://unfccc.int/documents/645358 https://www.worldwildlife.org/pages/climate-adaptation-and-resilience-program   Doug Parsons and Speaking Opportunities: If you are interested in having Doug speak at corporate and conference events, sharing his unique, expert perspective on adaptation in an entertaining and informative way, more information can be found here! Facebook, Linkedin and Twitter: https://www.facebook.com/americaadapts/ @usaadapts https://www.linkedin.com/in/doug-parsons-america-adapts/ Donate to America Adapts   Follow on Apple Podcasts Follow on Android Now on Spotify! List of Previous Guests on America Adapts Follow/listen to podcast on Apple Podcasts. Donate to America Adapts, we are now a tax deductible charitable organization! Federal Reserve Bank of San Francisco Strategies to Address Climate Change Risk in Low- and Moderate-income Communities - Volume 14, Issue 1 https://www.frbsf.org/community-development/publications/community-development-investment-review/2019/october/strategies-to-address-climate-change-low-moderate-income-communities/   Podcasts in the Classroom – Discussion guides now available for the latest episode of America Adapts. These guides can be used by educators at all levels. Check them out here! The 10 Best Sustainability Podcasts for Environmental Business Leadershttps://us.anteagroup.com/news-events/blog/10-best-sustainability-podcasts-environmental-business-leaders Join the climate change adaptation movement by supporting America Adapts!  Please consider supporting this podcast by donating through America Adapts fiscal sponsor, the Social Good Fund. All donations are now tax deductible! For more information on this podcast, visit the website at http://www.americaadapts.org and don't forget to subscribe to this podcast on Apple Podcasts.   Podcast Music produce by Richard Haitz Productions Write a review on Apple Podcasts ! America Adapts on Facebook!   Join the America Adapts Facebook Community Group. Check us out, we're also on YouTube! Executive Producer Dr. Jesse Keenan Subscribe to America Adapts on Apple Podcasts Doug can be contacted at americaadapts @ g mail . com

After a short hiatus, the Great Trials team is back in action! This week, Steve and Yvonne interview Jake Plattenberger and Alan Holcomb of TorHoerman Law about the high-stakes legal battle, Margo Gill vs. Abbott Laboratories. The case revolves around a $495 million verdict awarded to Margo Gill, representing her daughter Robynn Davis, who suffered catastrophic injuries from necrotizing enterocolitis (NEC) after being fed Similac Special Care 24 formula by Abbott Labs.    Remember to rate and review GTP in iTunes: Click Here to Rate and Review   Case Details: Margo Gill's premature infant daughter, Robynn Davis, was born on August 26, 2021, at SSM St. Mary's Hospital in St. Louis, Missouri. Shortly after birth, doctors transferred Robynn to Cardinal Glennon Children's Hospital, where she was fed Similac cow's milk-based formula, manufactured by Abbott Laboratories. After consuming these products, Robynn developed necrotizing enterocolitis (NEC), a life-threatening gastrointestinal disease that primarily affects premature infants. As a result of NEC, Robynn required extensive surgery and now faces long-term health complications. The complaint alleged that Abbott Laboratories, along with sales representatives Matthew McClure and Tara Todd, aggressively marketed their cow's milk-based formula as safe for premature infants, despite being aware that it significantly increased the risk of NEC. It also claims Abbott failed to provide adequate warnings about the risks of NEC. Additionally, Abbott falsely promoted their formula as essential for the growth and development of preterm infants. (Source)   Guest Bios: Jake Plattenberger Since joining TorHoerman Law in 2009, Jacob Plattenberger has taken hundreds of depositions, argued in countless hearings, and tried over thirty-five (35) cases to a jury. His experience in and out of the courtroom has made him a passionate advocate for those injured due to the negligence of others. Jake started his career trying cases at one of the busiest civil courthouses in the country – the Richard J. Daley Center in downtown Chicago. He started out doing insurance defense because he knew that afforded him the best opportunity to get courtroom experience. “When I was working on the defense side, I always knew that I was going to be a plaintiff's lawyer. I knew that being able and willing to try a case to a jury was a skill that I needed to have if I was going to be able to offer my clients the best legal representation. Insurance companies and corporate defendants need to believe you when you say you will take them to trial – they need to fear that.” This type of real trial experience is exceedingly rare in complex civil litigation and having seen it from the defense side gives Jake an added advantage. Read Full Bio   Alan Holcomb Alan Holcomb brings over a decade of experience handling catastrophic injury cases to the team. Widely recognized for his legal advocacy and broad experience as a trial lawyer, Alan has handled cases in more than 20 states nationwide.  Alan works on cases ranging from products liability, severe burn injuries, wrongful death, chemical exposure, car accidents, lung disease, negligent security, and more. He puts his diverse expertise to work for his clients every day, dedicating his life to representing the people. After earning his undergraduate degree from the University of Georgia, Alan received his juris doctorate from Emory University School of Law. Before forming Turnbull, Holcomb & Moak, Alan was an equity partner at one of the top insurance defense firms in the country, where he represented some of the largest companies in the world and acted as national coordinating counsel for a large chemical/flavor manufacturer. This experience taught Alan that he wanted to help equalize the power imbalance between well-funded corporations and consumers, leading him to a career fighting for the people as a plaintiff's attorney. Licensed in Georgia, California, Mississippi, and Ohio, Alan is determined to hold major corporations accountable. He relentlessly pursues justice, passionately advocating for his clients every step of the way. Read Full Bio   Links: TorHoerman Law on Facebook: THLawyers Check out previous episodes and meet the GTP Team: Great Trials Podcast   Show Sponsors: Harris Lowry Manton LLP - hlmlawfirm.com   Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2

Earn 0.1 ASHA CEU for this episode with Speech Therapy PD: www.speechtherapypd.com/course?name=Feeding-Matters-Leading-the-Way-for-ARFID-and-PFDIn the first episode of 2025, Michelle is joined by Jaclyn Pederson, MHI, CEO of Feeding Matters, and William Sharp, PhD, Director of Children's Multidisciplinary Feeding Program (Atlanta, GA) and Professor at Emory University School of Medicine, to lay the foundation for a year of combining passion, advocacy, and learning. These guests share their expertise and highlights from a recent journal publication on how the diagnoses of “Pediatric Feeding Disorder” and “Avoidant Restrictive Feeding Intake Disorder” are individualistic while simultaneously overlapping to capture the unique needs of the little ones on our caseloads. Additionally, they share practical insight into the roles and responsibilities of various team members, such as the SLP and the psychologist, in evaluating and treating these little ones as part of an interprofessional practice team.About the Guests: Jaclyn Peterson, MHI: With more than a decade of experience in program development, Jaclyn Pederson's broad knowledge of programming in the public and social sectors includes program and strategic initiative design, fund development, special events, grant writing, and community engagement. A system thinker and positive team builder, she uses transformational leadership principles to develop energized and efficient workgroups that influence significant organizational and systemic change for all affected by pediatric feeding disorder –such as the development of the expanded PFD Alliance. Jaclyn also manages Feeding Matters' strategic partnerships with numerous professional associations, including the American Speech-Language-Hearing Association (ASHA), the American Society of Parenteral and Enteral Nutrition, and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).William Sharp, PhD is a clinical psychologist and professor in the department of pediatrics at Emory University School of Medicine. He is also the Director of Children's Healthcare of Atlanta's Multidisciplinary Feeding Program. In this role, Dr. Sharp leads a team of professionals that includes psychologists, physicians, speech-language pathologists, and dietitians who evaluate and treat children with pediatric feeding disorder and avoidant restrictive food intake disorder (ARFID). His research interest focuses on identifying the cause, consequences, and treatment of chronic food refusal in pediatric populations. His most recent work involves developing and evaluating a training curriculum for therapists to deliver a manual-based intervention for food selectivity - or extremely narrow dietary in children with ARFID.Hosted by: Michelle Dawson MS, CCC-SLP, CLC, BCS-SWatch the full video interview on YouTube: https://www.youtube.com/@speechtherapypd

Welcome back to another episode of the Mind Gut Conversation. Today's guest is Andrew H. Miller, MD. Dr. Miller is an internationally recognized expert in interactions between the brain and immune system as they relate to depression and has conducted the first clinical trial examining the efficacy of an immunotherapy for the treatment of depression. He is the William P. Timmie Professor and Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia. In addition to publishing over 300 scientific papers, Dr. Miller has won numerous research, teaching and mentoring awards, and has been nominated as a "Top Doctor" in Psychiatry for the past 3 years. In this episode of the Mind Gut Conversation, I sit down with Dr. Miller, to discuss the role of inflammation in mental disorders, and the therapeutic consequences that come from this novel understanding of depression. During the episode, we talk about a wide range of topics, addressing the following questions and topics: • Is depression an inflammatory disorder of the brain? • Role of the gut-associated immune system • Effectiveness of anti-inflammatory drugs in the treatment of depression • Psychedelics in psychiatry We hope you enjoy the episode! Learn more at www.emeranmayer.com

Join endocrine experts Vin Tangpricha, MD, PhD, FACE, Editor-in-Chief of Endocrine Practice (EP) and Professor of Medicine at Emory University School of Medicine, and Rifka C. Schulman-Rosenbaum, MD, FACE, FACP, Director of Inpatient Diabetes at Long Island Jewish Medical Center, Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Northwell Health, and Chair Elect for the AACE 2025 Annual Meeting, as they discuss Dr. Schulman-Rosenbaum's EP article, “Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia.” Tune in as they explore the complexities of managing inpatient hyperglycemia, the risks of SGLT-2 inhibitors in hospitalized patients, and who might be good candidates for safer alternatives like DPP-4 inhibitors and insulin. Packed with valuable insights and practical strategies, this discussion is essential for optimizing hospital-based diabetes care. Read the full article in the April 2024 issue of EP here.

Did you know that there's a way to detect if you're at risk for the leading cause of death in America? Tune in for Katherine Wilemon is the founder and CEO of the Family Heart Foundation & Laurence S. Sperling, M.D., Chief Medical Officer for the Family Heart Foundation on Cardiovascular Disease.Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM ABC Talk News Radio affiliate!  Katherine Wilemon is the founder and CEO of the Family Heart Foundation (formerly the FH Foundation), a leading research and advocacy non-profit dedicated to reducing heart disease and stroke by advancing the understanding and care of familial hypercholesterolemia (FH) and elevated Lipoprotein(a) [Lp(a)].  https://familyheart.orgLaurence S. Sperling, M.D., FACC, FAHA, FACP, MASPC serves as the Chief Medical Officer for the Family Heart Foundation, a non-profit organization focused on timely identification and improved care of people living with familial hypercholesterolemia and elevated Lp(a) through research, advocacy, and education. He is the Founder and was the Director of The Heart Disease Prevention Center at Emory (1997-2019).  He is currently the Katz Professor in Preventive Cardiology at the Emory University School of Medicine, and Professor of Global Health in the Rollins School of Public Health. https://familyheart.orgFor more show information visit: www.MariannePestana.com

This week, we are joined by Dr. Ami Klin, the Director of the Marcus Autism Center and a leading expert in autism research. We will be discussing his groundbreaking work with Dr. Warren Jones, utilizing eye-tracking technology to visualize and measure social engagement in individuals with autism. Ami Klin, Ph.D. is the Georgia Research Alliance Eminent Scholar Professor and Chief of the Division of Autism and Developmental Disabilities at Emory University School of Medicine, and Director of the Marcus Autism Center at Children's Healthcare of Atlanta. He obtained his Ph.D. from the University of London, and completed clinical and research post-doctoral fellowships at the Yale Child Study Center. He directed the Autism Program at the Yale Child Study Center, Yale University School of Medicine, until 2010, where he was the Harris Professor of Child Psychology & Psychiatry. The Marcus Autism Center is one of the largest centers of clinical care and science focused on autism and related conditions in the country. Dr. Klin's primary research activities focus on social mind and social brain, and on developmental aspects of autism from infancy through adulthood. These studies include a longstanding collaboration with Dr. Warren Jones focused on novel science-based technologies developed and clinically validated to address limited access to high quality early diagnosis and assessment of autism. He is the author of over 250 publications in the field of autism and related conditions.  Download to learn more! ............................................................... Autism weekly is now found on all of the major listening apps including apple podcasts, google podcasts, stitcher, Spotify, amazon music, and more. Subscribe to be notified when we post a new podcast. Autism weekly is produced by ABS Kids. ABS Kids is proud to provide diagnostic assessments and ABA therapy to children with developmental delays like Autism Spectrum Disorder. You can learn more about ABS Kids and the Autism Weekly podcast by visiting abskids.com.  

In this episode Dr. Zanotti discusses the current role of pulmonary artery catheters in critical care medicine. He is joined by Dr. Steven Hollenberg a critical care and cardiology physician. Dr. Hollenberg is a professor of medicine at Emory University School of Medicine and director of cardiac intensive care at the Emory Heart & Vascular Center. Additional resources: Pulmonary Artery Catheter Use and Risk of In-hospital Death in Heart Failure Cardiogenic Shock. Kanwar MK, et al. J Card Fail. 2023 Sep;29(9):1234-1244: https://pubmed.ncbi.nlm.nih.gov/37187230/ Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit. Bernard S Kadosh, et al. JACC Heart Failure 2023: https://pubmed.ncbi.nlm.nih.gov/37318422/ Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality. A Reshad Garan, et al. JACC Heart Failure 2020: https://pubmed.ncbi.nlm.nih.gov/33121702/ Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database. Sagar Ranka, et al. J Am Heart Assoc 2021: https://pubmed.ncbi.nlm.nih.gov/34423652/ Books mentioned in this episode: I Contain Multitudes: The Microbes Within Us and a Grander View of Life. By Ed Yong: https://www.amazon.com/Contain-Multitudes-Microbes-Within-Grander/dp/0062368605/ref=sr_1_1?crid=1EVOY6OVQZ437&dib=eyJ2IjoiMSJ9.Na-UJShWq7ngsH9dxvSV2Q.Ob-k26_k01p5WzKzo4CWnsvD4Jjq9RU1krhQhmUi9u4&dib_tag=se&keywords=I+contain+platitudes&qid=1732299607&sprefix=i+contain+platitudes%2Caps%2C132&sr=8-1 Kind of Blue. Miles Davis: https://www.amazon.com/Kind-Blue-Vinyl-Miles-Davis/dp/B0041TM5OU/ref=sr_1_2?crid=E6F0PBPV33BG&dib=eyJ2IjoiMSJ9.4Kk2sCHn8DAOl9j_qadqsZPMVZPlOuKNXg9vv_NTPEYrl10vHYNIC5-wrGJeFpn9K8rSS8aspG9zhJHjAyDqiIUiC9VKvvHjzQsAGmr4wP9VWUPWumInjcS72CDmoaEYr3h2Uoiy8yt-YfYFHm7Y-6XoPecnwju8_zumwohrrhYWC0X6rR8Ui3Xhp6ILDU3sBNb50TJ6iq_fjataiHX7X6fBL1YnUo3X-uBcnQVfKtc.v-zGaYaLVvE7BGxS1c-2_Brbwsq1kAxVKEuxqsaBci8&dib_tag=se&keywords=Miles+Davis+Kind+of+Blue&qid=1732299762&sprefix=miles+davis+kind+of+blue%2Caps%2C139&sr=8-2 Brahms: Ein Deutsches Requiem. Sir Simon Rattle: https://www.amazon.com/Brahms-Ein-Deutsches-Requiem-German/dp/B000MTEDIE/ref=sr_1_5?crid=2UCHLINLHSETV&dib=eyJ2IjoiMSJ9.aDG2ZKyB5OnEgO3Z6_VOsNplIVSXmtXffLy2Jrylq4vgaRHEYDyBsz_4YG1fE_88IJxJ2ScnxhBvvDkVZjauoazwhTEMef0o_nJN25zUb_7oXFNkPMo_U4WBLhgK5njVOkm2ae67weI5roWsx-KbokunvjgAf-tXngA30o2xDQxh0-9y0kJbJRdKtVY63PcPv3yp9YdOrpgo2PO-gpspQsio7uJ-dgz5SY1vX1je3U4.aMm-IxbuxnZSIacaIBGZWc36GYliQP4r-9f9-SBq5tQ&dib_tag=se&keywords=Brahms+requiem&qid=1732299866&sprefix=brahms+requiem%2Caps%2C142&sr=8-5e

Welcome to the Sustainable Clinical Medicine Podcast, where we explore innovative strategies for creating more efficient and balanced clinical days. Today, we have the pleasure of speaking with Dr. Jattu Senesie, a board-certified OBGYN who has courageously reshaped her career to prioritize well-being and sustainability. Dr. Senesie shares her transformative journey from enduring the pressures and expectations of traditional medical practice to becoming a renowned coach for early-career physicians, focusing on intentional career transitions and life design. Join us as we explore how Dr. Senesie overcame feelings of dissatisfaction and burnout, and learn valuable strategies for keeping well-being at the core of your professional journey. Whether you're navigating the challenges of medical training or seeking a more sustainable approach to your career, this episode provides a wealth of wisdom and encouragement. Here are 3 key takeaways from this episode: Start with Well-being: Success and personal fulfillment can coexist. It's crucial to incorporate well-being as a cornerstone in your career and life planning. Shift from Survival to Sustainability: Move beyond the survival mindset from medical training and cultivate habits that respect your own priorities as well as those of others. Recognize and Address Needs Early: Be proactive about understanding and meeting your personal needs to avoid burnout and enhance career longevity. Dr. Jattu Senesie Bio: Dr. Jattu Senesie is a board-certified obstetrician-gynecologist, self-described recovering pathological altruist and native of the Washington DC metropolitan area. She is an alumna of the University of Maryland Baltimore County where she graduated magna cum laude with a degree in Biological Sciences. Her medical training took her to Emory University School of Medicine in Atlanta, GA. There she obtained her medical degree and completed her residency training in the Department of Gynecology and Obstetrics. Dr Senesie returned to the DC area after training and spent six years in a private obstetrics and gynecology practice in Maryland. Dr Senesie retired from clinical practice at age 35 in an attempt to find a balance between maintaining her own sense of well-being and living a life of service. Since leaving clinical medicine, she has become a personal and professional development coach and physician satisfaction specialist through her business Essence of Strength. Because of her own experience, Dr Senesie's particular passion is helping early career physicians to be as intentional about the factors impacting their sense of satisfaction and well-being as they have been about those contributing to their success. Through individual coaching, workshops, writing and speaking, she seeks to help her fellow healthcare professionals develop the mindset and the methods necessary to sustain their full potential inside and outside the clinical setting. -------------- **** Charting Champions is a premiere, lifetime access Physician only program that is helping Physicians get home with today's work done. All the proven tools, support and community you need to create time for your life outside of medicine. Learn more at https://www.chartingcoach.ca **** Enjoying this podcast? Please share it with someone who would benefit. Also, don't forget to hit “follow” so you get all the new episodes as soon as they are released. **** Come hang out with me on Facebook or Instagram. Follow me @chartingcoach to get more practical tools to help you create sustainable clinical medicine in your life. **** Questions? Comments? Want to share how this podcast has helped you? Shoot me an email at admin@reachcareercoaching.ca. I would love to hear from you.

In this episode of Real Talk with Kid Docs we are joined by Dr. Amit Shah, M.D., a fellowship trained Pediatric Pulmonologist and Sleep Medicine physician in Atlanta, Georgia. In addition to his inpatient and outpatient clinical responsibilities, he serves as Assistant Professor in Pediatrics at Emory University School of Medicine. He joins us to talk about the importance of sleep for our children, the role that restful sleep serves in promoting emotional and behavioral regulation, neural development and more. He reviews sleep hygiene and the basics of good sleep. You don't want to miss this! (And, more to come for him in the new future!)Let us know your sleep questions! Email us at RealTalkwithKidDocs@gmail.com or message us on Instagram @RealTalkwithKidDocs

Send us a textPreventative legal advocacy is reshaping the future of child welfare, and Emily Cook is at the forefront. As a Senior Staff Attorney at the Barton Child Law and Policy Center, Emilie Cook shares her journey from traditional legal practice to becoming a champion for systemic change. This episode explores how neglect, often rooted in poverty, not abuse, constitutes a significant issue within the child welfare system. We unpack the racial disparities faced by marginalized communities and how preventive measures can address these injustices by offering legal support early on, tackling social determinants of health, and redefining systemic approaches for a more equitable future.We discuss the effectiveness of the current child welfare system, highlighting the unnecessary trauma caused by child-parent separations. Emily shares insights into the barriers families face, such as housing and resource instability, that can perpetuate involvement in the system. Our discussion is a call to action for community and nonprofit leaders to embrace community-based solutions, fostering resilience and stability rather than perpetuating cycles of trauma and poverty. Emilie's work in Georgia and around the country exemplifies the power of collaboration, as she builds networks to advance preventative advocacy and support families before they reach crisis points.Emilie's transformative work isn't just theoretical; it's a practical approach to reimagining support systems that serve families better. We explore her efforts in creating a learning cohort dedicated to preventive legal advocacy and discuss the importance of evaluating program outcomes to secure sustainable funding. With a focus on effectiveness, Emily's initiatives demonstrate how legal interventions can address systemic issues like housing instability, proving that change is not only necessary but also achievable. Join us for an episode rich with insights and strategies that challenge the status quo and advocate for a more just and supportive child welfare system.Guest BioEmilie Cook is Senior Staff Attorney at the Barton Child Law & Policy Center at Emory University School of Law in Atlanta, Georgia, where she works on projects to promote and protect the legal interests of children involved with the child welfare, juvenile court, and juvenile justice systems. Through her work in the preventive legal advocacy space, Emilie works with interdisciplinary legal teams and advocates across the country to promote and support the provision of high-quality legal advocacy and upstream support services designed to address thesocial determinants of health and protect against the effects of poverty, systemic racism, and other forms of discriminatioLike what you heard? Please like and share wherever you get your podcasts! Connect with Ann: Community Evaluation Solutions How Ann can help: · Support the evaluation capacity of your coalition or community-based organization. · Help you create a strategic plan that doesn't stress you and your group out, doesn't take all year to design, and is actionable. · Engage your group in equitable discussions about difficult conversations. · Facilitate a workshop to plan for action and get your group moving. · Create a workshop that energizes and excites your group for action. · Speak at your conference or event. Have a question or want to know more? Book a call with Ann .Be sure and check out our updated resource page! Let us know what was helpful. Music by Zach Price: Zachpricet@gmail.com

In this compelling and informative interview, Carrie N. Baker discusses her newest book, Abortion Pills: US History and Politics (Amherst College Press, 2024). This book is the first comprehensive history of abortion pills in the United States, and Baker examines the actions of scientists, policy-makers, pharmaceutical companies, pro-abortion rights activists and anti-abortion forces as the abortion pill was developed in France in 1980, and subsequently brought to market in the United States. She carefully investigates the fight for FDA approval of the abortion pill, and reproductive rights advocates' work to expand access. She pays particular attention to the critical period of 2020-2024 when in the midst of the COVID-19 pandemic telemedicine abortion became a possibility. Baker ends exploring attempts to restrict abortion pills and self-managed abortions in the wake of the Dobbs v. Jackson Women's Health Organization Supreme Court decision. In this thoroughly researched history, Baker draws on interviews with over 80 activists, abortion providers, researchers, and people who have used abortion pills to demonstrate the range of actors involved in efforts to expand access to abortion pills. In addition, she analyzes medical research, government records, legal cases, and the archives of several reproductive health organizations. Abortion Pills: US History and Politics is available open-access starting December 3, 2024. Click the following link to see a PDF of the book Carrie N. Baker holds a B.A. in Philosophy from Yale University, a J.D. from Emory University School of Law, and an M.A. and Ph.D. from Emory's Institute of Women's, Gender, and Sexuality Studies. She is the Sylvia Dlugasch Bauman Chair of American Studies and Professor of the Study of Women, Gender and Sexuality Studies at Smith College where, as a legal and social movement scholar, she teaches courses on gender, law and public policy; feminist social movements; and feminist public writing. In addition to publishing peer-reviewed academic scholarship, Baker also serves as a regular writer and contributing editor for Ms. Magazine, has a monthly column in the Daily Hampshire Gazette, and hosts Feminist Futures, a radio program on WHMP 101.5 FM in Northampton, Massachusetts. Jessie Cohen holds a Ph.D. in History from Columbia University, and is an editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this compelling and informative interview, Carrie N. Baker discusses her newest book, Abortion Pills: US History and Politics (Amherst College Press, 2024). This book is the first comprehensive history of abortion pills in the United States, and Baker examines the actions of scientists, policy-makers, pharmaceutical companies, pro-abortion rights activists and anti-abortion forces as the abortion pill was developed in France in 1980, and subsequently brought to market in the United States. She carefully investigates the fight for FDA approval of the abortion pill, and reproductive rights advocates' work to expand access. She pays particular attention to the critical period of 2020-2024 when in the midst of the COVID-19 pandemic telemedicine abortion became a possibility. Baker ends exploring attempts to restrict abortion pills and self-managed abortions in the wake of the Dobbs v. Jackson Women's Health Organization Supreme Court decision. In this thoroughly researched history, Baker draws on interviews with over 80 activists, abortion providers, researchers, and people who have used abortion pills to demonstrate the range of actors involved in efforts to expand access to abortion pills. In addition, she analyzes medical research, government records, legal cases, and the archives of several reproductive health organizations. Abortion Pills: US History and Politics is available open-access starting December 3, 2024. Click the following link to see a PDF of the book Carrie N. Baker holds a B.A. in Philosophy from Yale University, a J.D. from Emory University School of Law, and an M.A. and Ph.D. from Emory's Institute of Women's, Gender, and Sexuality Studies. She is the Sylvia Dlugasch Bauman Chair of American Studies and Professor of the Study of Women, Gender and Sexuality Studies at Smith College where, as a legal and social movement scholar, she teaches courses on gender, law and public policy; feminist social movements; and feminist public writing. In addition to publishing peer-reviewed academic scholarship, Baker also serves as a regular writer and contributing editor for Ms. Magazine, has a monthly column in the Daily Hampshire Gazette, and hosts Feminist Futures, a radio program on WHMP 101.5 FM in Northampton, Massachusetts. Jessie Cohen holds a Ph.D. in History from Columbia University, and is an editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

In this episode of Audible Bleeding, editor Dr. Imani McElroy (@IEMcElroy) is joined by General Surgery PGY-4 Sasank Kalipatnapu(@ksasank) along with Dr.David Rigberg, MD (@drigberg), and Dr. Guillermo Escobar, MD (@GAEscobarMD) to discuss the Society for Clinical Vascular Surgery (SCVS) Rising Seniors / Incoming Fellows Program. This episode brings out a conversation exploring the history behind the development of the program, the current state of the program, and the overwhelming importance of the program in the current day. The episode also provides a broad overview of the content presented in the program and the reasoning behind the talks.    Guests: Dr. David Rigberg - Professor of Surgery, Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Program Director for the Vascular fellowship and integrated vascular surgery residency at the David Geffen School of Medicine, UCLA, Los Angeles, California Dr. Guillermo Escobar- Associate Professor, Division of Vascular Surgery and Endovascular Therapy, Program Director for the Vascular Surgery Fellowship and Residency at Emory University School of Medicine   Relevant links: Rising Seniors / Incoming Fellows Program - Program Details SCVS - Fellows & Chief Residents Program SCVS - Young Vascular Surgeons Program   To apply for the Rising Seniors / Incoming Fellows Program, go to apply now! Audible Bleeding team: Dr. Imani McElroy is 1st year vascular surgery fellow at USC/LA and editor at Audible Bleeding Dr. Sasank Kalipatnapu, PGY-4 general surgery resident, Dept of Surgery, UMass Chan Medical School, Worcester, MA Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

For today's special episode, Lawfare General Counsel and Senior Editor Scott R. Anderson held a series of conversations with contributors to a special series of articles on “The Dangers of Deploying the Military on U.S. Soil” that Lawfare recently published on its website, in coordination with our friends at Protect Democracy.Participants include: Alex Tausanovitch, Policy Advocate at Protect Democracy; Laura Dickinson, a Professor at George Washington University Law School; Joseph Nunn, Counsel in the Liberty and National Security Program at the Brennan Center; Chris Mirasola, an Assistant Professor at the University of Houston Law Center; Mark Nevitt, a Professor at Emory University School of Law; Elaine McCusker, a Senior Fellow at the American Enterprise Institute; and Lindsay P. Cohn, a Professor of National Security Affairs at the U.S. Naval War College. Together, they discussed how and why domestic deployments are being used, the complex set of legal authorities allowing presidents and governors to do so, and what the consequences might be, both for U.S. national security and for U.S. civil-military relations more generally.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/c/trumptrials.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.